The host defense of Drosophila melanogaster by Lemaitre, Bruno & Hoffmann, Jules
ANRV306-IY25-24 ARI 11 February 2007 13:14
The Host Defense of
Drosophila melanogaster
Bruno Lemaitre1 and Jules Hoffmann2
1Centre de Ge´ne´tique Mole´culaire, CNRS, 91198 Gif-sur-Yvette, France;
email: lemaitre@cgm.cnrs-gif.fr
2Institut de Biologie Mole´culaire et Cellulaire, UPR 9022 du CNRS, 67084
Strasbourg Cedex, France; email: J.Hoffmann@ibmc.u-strasbg.fr
Annu. Rev. Immunol. 2007. 25:697–743
First published online as a Review in Advance on
January 2, 2007
The Annual Review of Immunology is online at
immunol.annualreviews.org
This article’s doi:
10.1146/annurev.immunol.25.022106.141615
Copyright c© 2007 by Annual Reviews.
All rights reserved
0732-0582/07/0423-0697$20.00
Key Words
insect immunity, Toll, Imd, recognition, pathogens
Abstract
To combat infection, the fruit ﬂy Drosophila melanogaster relies on
multiple innate defense reactions, many of which are shared with
higher organisms. These reactions include the use of physical bar-
riers together with local and systemic immune responses. First, ep-
ithelia, such as those beneath the cuticle, in the alimentary tract, and
in tracheae, act both as a physical barrier and local defense against
pathogens by producing antimicrobial peptides and reactive oxygen
species. Second, specialized hemocytes participate in phagocytosis
and encapsulation of foreign intruders in the hemolymph. Finally,
the fat body, a functional equivalent of the mammalian liver, pro-
duces humoral response molecules including antimicrobial peptides.
Here we review our current knowledge of the molecular mecha-
nisms underlying Drosophila defense reactions together with strate-
gies evolved by pathogens to evade them.
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AMP: antimicrobial
peptide
RNAi: RNA
interference
INTRODUCTION
Insects and microorganisms coexist within the
biosphere in numerous ways. Frequently, in-
sect larvae develop in decaying organic mat-
ter, and insect adults often serve as vectors
for microorganisms causing plant and ani-
mal diseases. Thus insects have evolved sensi-
tive mechanisms for recognition of pathogens
and an array of strategies to defend them-
selves against attacks by bacteria, fungi, par-
asites, and viruses. To combat infection, the
fruit ﬂy Drosophila melanogaster relies on mul-
tiple innate defense reactions that are par-
tially shared with higher organisms (1–4)
(Figure 1). The mechanisms regulating these
immune responses have been largely uncov-
ered with the aid of genetic and molecular
studies in Drosophila. The key role of the
Drosophila model for studying immunity was
illustrated by the initial genetic identiﬁcation
of signaling pathways mediating antimicrobial
peptide (AMP) gene expression (5). Relatives
of the Toll receptor protein, the cell surface
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Figure 1
Schematic overview of Drosophila host defense. Detection of microbial pathogens elicits a large array of
interconnected and synergistic defense modules in immune-responsive tissues.
receptor of the Drosophila Toll signaling path-
way, also regulate innate immune responses
in mammals. The conservation of a signal-
ing pathway for the activation of antimicrobial
defense responses suggests that some compo-
nents of innate immunity share an ancient ori-
gin in metazoan evolution and demonstrates
that Drosophila is a potent model for deci-
phering general innate immune mechanisms
in animals. Investigations on the highly efﬁ-
cient immune reactions in this Dipteran in-
sect have also provided information on other
insects that have dramatic repercussions on
human life as agricultural pests or as vectors
for diseases such as malaria (e.g., the mosquito
Anopheles).
The completion of the Drosophila ge-
nomic sequence in 2000 (6) and the subse-
quent expansion of new postgenomic tech-
nologies including proteomics, microarrays,
and RNAi (RNA interference) have consid-
erably widened the possibilities of immune
system analysis in this model organism. This
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article presents an overview of our current
knowledge of the Drosophila immune response
in the context of two fundamental ques-
tions: (a) What are the molecular mechanisms
underlying the defense reactions? (b) How
does each of these mechanistic modules con-
tribute to defense during an infection, and
what strategies have been developed by the
pathogens to evade them?
REPERTOIRE OF DROSOPHILA
DEFENSE MECHANISMS
A hallmark of the Drosophila host defense, and
that of most other holometabolous insects,
is the challenge-induced synthesis and secre-
tion of potent AMPs that accumulate in the
hemolymph where they oppose invading mi-
croorganisms. Although synthesis of AMPs
is probably common to all metazoans, secre-
tion of these molecules into the hemolymph
is not a general phenomenon. We refer it to
as the “systemic immune response,” which is
by far the best analyzed among Drosophila im-
mune reactions, and analyze it from the syn-
thesis of immune effectors to recognition of
infection. Epithelial immunity, i.e., the ﬁght
against invading microorganisms at the level
of the barrier epithelia, is now understood
to signiﬁcantly contribute to the protection
of Drosophila. This response is analyzed next
both in terms of AMP and reactive oxygen
species (ROS) production. A subsequent sec-
tion deals with the cellular response by the
hemocytes, especially their role in phagocy-
tosis and encapsulation of parasites. The ﬁnal
section is devoted to two reactions, coagula-
tion and melanization, which are activated im-
mediately upon injury.
The Systemic Immune Response
Injection of bacteria into the body cavity in-
duces the appearance of antimicrobial activity
in the hemolymph of Drosophila. This activity
persists for several days and can confer protec-
tion against a second challenge by pathogenic
bacteria (7). This reaction mainly consists of
ROS: reactive
oxygen species
AMP production by the fat body, which is
a major immune-responsive tissue that origi-
nates from the mesoderm during embryoge-
nesis and acquires its immune competence at
the onset of the ﬁrst larval stage. Due to its
large size and its location inside the open cir-
culatory system of the insect body cavity, the
fat body represents a powerful organ for the
synthesis and secretion of peptides into the
hemolymph, where they readily reach their
effective concentrations.
Immune effectors. Among the various
molecules produced by the fat body in re-
sponse to infection, AMPs are the best char-
acterized. Some 20 immune-inducible AMPs,
which can be grouped into seven classes,
have been identiﬁed (Figure 2). They are
small (<10 kDa), with the exception of the
25 kDa Attacin, and cationic and exhibit
a broad range of activities against bacte-
ria and/or fungi (8). Diptericin, Drosocin,
and Attacin are very effective against Gram-
negative bacteria (9–11). Defensin is active
against Gram-positive germs (12), whereas
Drosomycin and Metchnikowin are antifun-
gal agents (13, 14). Cecropin A1 acts against
both bacteria and some fungi (15, 16). De-
fensins and Cecropins have been reported
from many insects, whereas Drosomycin and
Metchnikowin have so far been identiﬁed
only in Drosophilidae (8). The insect AMPs
are membrane-active, and their precise mode
of action at the membrane level is still un-
der investigation. Some AMPs are very sta-
ble owing to the presence of intramolecu-
lar disulﬁde bridges and are still detected in
the hemolymph several weeks after challenge
(17). Experiments with transgenic ﬂies over-
expressing a single AMP provided support for
a critical role of AMPs in resistance to infec-
tion in Drosophila (18). However, the particu-
lar contributions of each of these AMPs have
not been tested, as loss-of-function mutants
for AMP genes are not available to date.
Recent large-scale analyses, at the tran-
scriptome and proteome levels, have re-
vealed that in addition to that of AMPs, the
www.annualreviews.org • Host Defense of Drosophila melanogaster 699
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Figure 2
Drosophila antimicrobial peptides. Name, number of genes in the genome, antimicrobial activities,
estimated concentration in the hemolymph after bacterial injection, and 3-D structure (8) (nd, not
determined).
DIM: Drosophila
immune molecule
production of many peptides and proteins is
upregulated after septic injury (19–25).1 Some
of these are involved in the regulation of the
1A list of all Drosophila immune genes can be found
on the web at http://www.cgm.cnrs-gif.fr/immunity/
enindex.html.
systemic immune response itself (e.g., signal-
ing components). Another group of proteins
(opsonins, components of the melanization
or clotting system) participates in distinct de-
fense mechanisms, while an additional group
includes putative immune effectors. Among
these are 17 members of the DIM family
700 Lemaitre · Hoffmann
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(Drosophila immune molecule) and 8 Turandot
proteins, which are small peptides of unknown
functions secreted by the fat body (17, 25–
27). One catalase gene, two transferrin genes,
and one iron transporter gene are also in-
duced following septic injury, pointing to a
role of ROS and iron sequestration in the con-
trol of microbial development (19, 28). Iron
is essential for most invading microorganisms
during the course of an infection, and both
animals and plants have elaborated immune
strategies that limit iron availability to the
microorganisms.
Collectively, the systemic antimicrobial re-
sponse represents a dramatic change in gene
expression that not only results in the pro-
duction of antimicrobial molecules in the
hemolymph, but also participates in other im-
mune mechanisms. Major challenges are to
understand the relative contribution of these
immune effectors to the total host defense, to
test their speciﬁcity against certain pathogen
classes, and to determine potential synergies
between them.
Regulation. The massive expression of novel
peptides/polypeptides that occurs following
infection is primarily regulated at the tran-
scriptional level. The cloning in the early
1990s of the genes in D. melanogaster that
encode AMPs followed by promoter map-
ping experiments with the Cecropin A1 and
Diptericin genes revealed the presence of
DNA motifs required for immune inducibil-
ity. These include a combination of NF-κB
binding sites, GATA binding sites recognized
by the transcription factor Serpent, and a less
well-deﬁned motif called R1 (29–33). Promi-
nent among these motifs are the κB response
elements, which confer immune inducibility
(34–36). Three NF-κB/Rel-like proteins are
encoded in the Drosophila genome. Dorsal and
Dif, encoded by two clustered genes, contain
an N-terminal Rel DNA binding domain and
a C-terminal transactivator domain, whereas
Relish is similar to mammalian p105, con-
sisting of an N-terminal Rel domain and a
C-terminal inhibitory ankyrin repeat domain
(37–39a). Gel shift assays have shown that the
three proteins (Relish, Dorsal, and Dif ) bind
to κB sites and can transactivate some of the
AMP genes in cell culture (37, 38, 40, 41). Fur-
thermore, genetic studies have demonstrated
the key roles of these transactivators in the
regulation of AMP genes via two distinct sig-
naling pathways, referred to as Toll and Imd
pathways.
The Toll pathway. The Toll pathway is an
evolutionarily conserved signaling cascade
that plays a key role in the establishment
of the dorso-ventral axis of the Drosophila
embryo, as well as in several other devel-
opmental processes (42). Canonic compo-
nents of this pathway are the extracellu-
lar cytokine Spa¨tzle (which shares structural
similarities with the nerve growth factor,
NGF), the transmembrane receptor Toll, the
Tube and MyD88 adaptors, the Pelle kinase,
Cactus (the Drosophila homolog of IκB), and
the Dorsal and Dif transactivators (42, 43)
(Figure 3). Deletion of any of these compo-
nents (except for Cactus and Dorsal) causes
a similar immune-deﬁcient phenotype char-
acterized by the lack of expression of several
immune genes, including the antifungal pep-
tide Drosomycin gene, and a marked suscep-
tibility to fungal and Gram-positive bacterial
infection (44, 44a). Dif and Dorsal seem to
play redundant roles in the control of Dro-
somycin at the larval stage, whereas Dif is suf-
ﬁcient to mediate Toll activation in adults
(45–47). Subtle roles for Dorsal have been
proposed at the adult stage (48). Many compo-
nents of the Toll pathway are themselves up-
regulated in a Toll-dependent manner upon
infection (44, 49). The induction of the in-
hibitor molecule, Cactus, establishes a nega-
tive feedback on this cascade (50). Unlike ver-
tebrate Toll-like receptors (TLRs), Toll does
not function as a pattern recognition recep-
tor but is activated by the cytokine Spa¨tzle
(44, 51, 52). The Drosophila genome encodes
eight other Toll proteins, none clearly impli-
cated in ﬂy immunity (53, 54). The Drosophila
Toll pathway shares signiﬁcant similarities
www.annualreviews.org • Host Defense of Drosophila melanogaster 701
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with the signaling cascade activated down-
stream of Interleukin-1 and the TLRs, point-
ing to a common ancestry of these immune
mechanisms.
The Imd pathway. This pathway was initially
deﬁned by the identiﬁcation of a mutation
named immune deﬁciency (imd ) that impaired
the expression of several antibacterial pep-
tide genes but only marginally affected Dro-
somycin induction (55–57). imd ﬂies succumb
to Gram-negative bacteria but are more re-
sistant to fungi and Gram-positive bacteria
than are Toll mutant ﬂies. imd encodes a
death domain–containing protein similar to
that of Receptor Interacting Protein (RIP) of
the tumor necrosis factor receptor (TNF-R)
pathway, and its overexpression triggers the
transcription/induction of antibacterial pep-
TLR: Toll-like
receptor
TNF-R: tumor
necrosis factor
receptor
tide genes in the absence of an infection
(58). Genetic screens and reverse genetic ap-
proaches have led to the identiﬁcation of
eight additional canonical components of the
Imd pathway: the PGRP-LC receptor (59–
61); the Mitogen-Activated Protein 3 kinase
(MAP3K) TAK1 (62, 63); TAB2 (64–66);
DIAP2, a member of Inhibitor of Apop-
tosis proteins (64, 65, 67); IKKβ/ird5 and
IKKγ/Kenny, which form a Drosophila equiva-
lent of the mammalian IKK signalosome (68–
70); the dFADD adaptor (71, 72); the Dredd
caspase (73); and the transcription factor
Relish (74). Mutations affecting these factors
generate an immune deﬁciency similar to that
of imd. Noninfected imd-deﬁcient ﬂies are
perfectly viable, and to date no developmen-
tal role has been attributed to this pathway.
The Imd pathway shares some similarities
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Figure 3
Model of Toll and Imd pathway activation. (Top) Antimicrobial peptide genes are regulated by a balance
between two signaling pathways: the Toll pathway that is largely activated by fungi and Gram-positive
bacteria, and the Imd pathway that is mainly activated by Gram-negative bacteria. According to the κB
sites present in their promoters, antimicrobial peptide genes are more sensitive to either the Toll cascade
(e.g., Drosomycin) or the Imd cascade (e.g., Diptericin) or are coregulated. Toll pathway: The Toll receptor
is activated upon binding with a cleaved form of Spa¨tzle that is processed by proteolytic cascades
activated by secreted recognition molecules (PGRP-SA, PGRP-SD, GNBP1, GNBP3). Three distinct
recognition modules that involve the sensing of Gram-positive bacteria (PGRP-SA, PGRP-SD,
GNBP1), Glucan (GNBP3), and entomopathogenic fungi (via the direct cleavage of an SP) converge to
the activation of SPE that cleaves Spa¨tzle. Mature Spa¨tzle binds as a dimer to Toll, thereby inducing its
dimerization at the plasma membrane (51, 52). This causes the recruitment of three intracellular Death
domain–containing proteins, MyD88, Tube, and Pelle, the latter also being a kinase (43). By a
mechanism still uncharacterized, Cactus is phosphorylated, then degraded by the proteasome (50). As a
consequence, the Rel transcription factors Dif and Dorsal are released and move from the cytoplasm to
the nucleus (37, 142). Among the less well-understood aspects of this cascade are the respective roles of
the multiple Spa¨tzle isoforms, the mechanisms that link Pelle activation to Cactus degradation, and the
complex regulation of Cactus isoforms. Imd pathway: Upon direct binding with bacterial elicitors
(monomeric or polymeric DAP-type PGN), PGRP-LC recruits the adaptor Imd (127, 272). Imd then
interacts with dFADD, which itself binds the apical caspase Dredd (273). This caspase has been proposed
to associate with Relish, which it might cleave directly once Relish is phosphorylated (274, 275). After
Relish cleavage, the Rel domain translocates to the nucleus, whereas the inhibitory domain remains
stable in the cytoplasm. Relish is phosphorylated by the IKK signaling complex (68), which is itself
thought to be activated by TAK1 and its adaptor TAB2 in an Imd- and possibly dFADD-dependent
manner. The Ring domain protein DIAP2 may activate dTAK1. At present the mechanisms that link Imd
to the IKK complex and the precise role of TAK1 and DIAP2 are not known (see text). TIR (Toll-IL1
receptor domain), DD (death domain), DED (death-effector domain), ANK (ANKyrin repeats), Rel (Rel
homology domain), RING (RING ﬁnger domain), BIR (Baculovirus IAP repeat), SPE (Spa¨tzle
processing enzyme). (Bottom) Differential expression of Drosomycin (Toll target) and Diptericin (Imd
target) genes in response to injection of E. coli (Gram-negative bacteria) or M. luteus (Gram-positive
bacteria) (83). Diptericin shows an acute phase proﬁle, whereas Drosomycin exhibits a late and sustained
expression pattern.
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MAPK:
mitogen-activated
protein kinase
with the vertebrate TNF-R pathway. Several
proteins were recently identiﬁed that affect
the Imd pathway (64, 75–80a). The molecular
organization of the Imd pathway is, however,
as yet poorly deﬁned owing to difﬁculties in
performing epistatic analyses and to the ab-
sence of data on the subcellular localization
of most of its components (Figure 3).
Interactions between Toll and Imd pathways.
To date, the Toll and Imd pathways are the sole
reported intracellular cascades of Drosophila
that are activated by microbial ligands. Mi-
croarray studies using imd /Toll double mutant
ﬂies have shown that these cascades regulate
almost 80% of the genes induced upon sep-
tic injury, reﬂecting their important contribu-
tion in survival from infection (49). An open
question is whether the Toll and Imd pathways
can synergize to increase the levels of induc-
tion of some of the immune-response genes,
possibly via the formation of Dif/Relish het-
erodimers. Bioinformatic analysis has recently
identiﬁed κB binding sites speciﬁc for either
Toll or Imd pathway activation (81). Although
some immune-induced genes are clearly de-
pendent on one pathway only (Diptericin for
Imd, DIM1 for Toll), others can apparently
be induced by both cascades. Most notably,
Drosomycin, which is a convenient read-out
for Toll pathway activation, receives a modest
input from the Imd pathway in the systemic
response and is solely activated by the Imd
pathway in the local response (73, 82). The
susceptibility of Toll and imd mutants to differ-
ent classes of microorganisms is explained by
the differential activation of these two path-
ways by distinct microorganisms as well as by
the existence of speciﬁc immune target genes.
Another important aspect of the antimicrobial
response is the temporal activation of these
two pathways. Genes regulated by Imd gen-
erally show an acute phase proﬁle, whereas
Toll target genes exhibit a late and sustained
expression pattern (21, 47, 83) (Figure 3).
Finally, a number of developmental and
physiological factors affect Toll and Imd
signaling by inﬂuencing the maturation of
the fat body. This is reﬂected by the im-
mune inducibility of Diptericin in larvae,
which increases with age and is dependent
on ecdysone, the key molting hormone of in-
sects (84). All mutations affecting ecdysone
metabolism can thus indirectly affect the im-
mune response. This effect complicates im-
mune studies and may explain a number of
conﬂicting reports (85).
The JAK/STAT pathway. The JAK/STAT
pathway, originally identiﬁed through its role
in embryonic segmentation, has three main
cellular components: the receptor Domeless,
the Janus Kinase ( JAK) Hopscotch, and the
STAT transcription factor (86). The ﬁrst ev-
idence for an involvement of the JAK/STAT
pathway in insect immunity came from stud-
ies performed in the mosquito Anopheles in-
dicating that after an immune challenge the
STAT protein accumulates in the nucleus
(87). Subsequent gene expression proﬁle stud-
ies identiﬁed a subset of Drosophila immune-
responsive genes that are regulated by the
JAK/STAT pathway, namely the genes encod-
ing the complement-like protein Tep2 and the
Turandot stress genes (21, 88, 89). Turandot are
Drosophila-speciﬁc genes of unknown func-
tion that are induced by various stress con-
ditions, especially by septic injury (26, 27).
The transcriptional regulation of these genes
is complex, with additional inputs from both
the Imd and MAPK (mitogen-activated pro-
tein kinase) pathways (90).
JAK/STAT-deﬁcient ﬂies are as resistant to
bacterial and fungal infections as are wild-type
ﬂies, and they express a normal AMP proﬁle.
They are, however, sensitive to infection
with the Drosophila C virus (91). It has been
proposed that the JAK/STAT pathway could
respond to tissue damage and that a
hemocyte-released cytokine, Unpaired-3
(Upd-3), activates this pathway by binding
to the fat body Domeless receptor during
infection (89). The precise role of this
pathway and its overall contribution to the
host defense remain to be established.
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Other pathways. The JNK pathway reg-
ulates many developmental processes in
Drosophila and is required for proper wound
healing of the epidermis (92, 93). Microarray
analysis of S2 cells, a hemocyte-derived cell
line, has shown that TAK1 activates the JNK
pathway in response to bacteria via the JNK
kinase basket (21). These data are consistent
with a model where Imd signaling bifurcates
downstream of TAK1, activating both JNK
and IKK signaling (Figure 3). Some negative
feedbacks between the Imd-Relish and Imd-
JNK branches have been reported (94, 95). In
S2 cells, JNK-dependent immune genes en-
code many proteins involved in cytoskeleton
remodeling, in keeping with a role in hemo-
cyte activation (21). A role for the JNK path-
way in AMP gene expression by the fat body
has been proposed (96, 97).
The p38 stress pathway has been im-
plicated in the immune response of plants,
Caenorhabditis elegans, and mammals (98, 99).
The Drosophila genome encodes two ho-
mologs of p38, and cell culture experiments
identiﬁed several MAPKs acting upstream
(100, 101). Although there is no in vivo evi-
dence for a role of this pathway in the antimi-
crobial response, its implication in immune
functions remains possible. Eiger/Wengen
are Drosophila proteins with similarities to
mammalian TNF and TNF-R, respectively
(102, 103). Flies carrying a mutation in these
genes are fully viable and do not display ob-
vious immune defects. Overexpression of the
eiger and wengen genes, however, leads to
apoptosis via activation of the JNK pathway.
The physiological function of these proteins
has not yet been determined.
Microbial recognition. Injection of Gram-
positive or Gram-negative bacteria and fungi
induces different patterns of AMP expres-
sion, indicating that microbial recognition
mechanisms can differentiate between various
classes of invaders (83). This property favors
adapted effector responses via the selective ac-
tivation of the Toll and Imd pathways. Mi-
crobial detection is a process that ultimately
PRR: pattern
recognition receptor
PGRP:
peptidoglycan
recognition proteins
GNBP:
Gram-negative
binding protein
proPO:
prophenoloxidase
PGN:
peptidoglycan
DAP:
meso-diaminopimelic
acid
LPS:
lipopolysaccharide
requires direct contact between a host pro-
tein called pattern recognition receptor (PRR)
and a microbial molecule. Genetic studies
have shown that microbial recognition act-
ing upstream of the Toll and Imd pathways is
achieved through peptidoglycan recognition
proteins (PGRPs) and Gram-negative bind-
ing proteins (GNBPs), two families of PRRs
initially identiﬁed in larger insects for their
capacity to bind microbial ligands and to ac-
tivate the proPO (prophenoloxidase) cascade
(104–106).
Bacterial recognition by PGRPs. In
Drosophila, recognition of bacteria is achieved
through the sensing of speciﬁc forms of
peptidoglycan (PGN) by PGRPs. PGN is
an essential glucopeptidic polymer restricted
to the cell wall of both Gram-negative
and Gram-positive bacteria (Figure 4a). It
consists of long glycan chains of alternating
N-acetylglucosamine and N-acetylmuramic
acid residues that are cross-linked to each
other by short peptide bridges (107). PGN is
a highly complex and fast-evolving molecule
with marked differences from one bacterium
to another. PGN from Gram-negative
bacteria differs from most Gram-positive
PGN by the replacement of lysine with
meso-diaminopimelic acid (DAP) at the
third position in the peptide chain. There
is, however, a subclass of Gram-positive
bacteria including Bacillus species, which
produces DAP-type PGN. Another major
difference between Gram-negative and
Gram-positive PGN is its localization within
the cell wall. Gram-negative PGN consists of
a single layer and is hidden in the periplasmic
space underneath the outer membrane and
lipopolysaccharide (LPS) layer, whereas PGN
from Gram-positive bacteria is multilayered
and exposed at the bacterial surface.
The Imd pathway is activated by DAP-
type PGN, whereas the Toll pathway is acti-
vated by Lys-type PGN, as demonstrated by
studies using highly puriﬁed bacterial com-
pounds (108). In contrast to vertebrates, LPS
endotoxin, the major component of the
www.annualreviews.org • Host Defense of Drosophila melanogaster 705
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
Gram-negative cell envelope, has no ef-
fect on Toll and Imd pathway activ-
ity, and previous positive results were ex-
plained by the presence of PGN contami-
nants in commercial LPS preparations (108,
109).
Further studies have demonstrated that
both polymeric and monomeric DAP-type
PGN can activate the Imd pathway. A spe-
ciﬁc monomer, GlcNAc-MurNAc(anhydro)-
L-Ala-γ-D-Glu-meso-DAP-D-Ala monomer,
also known as tracheal cytotoxin (TCT), was
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identiﬁed as the minimal PGN motif capa-
ble of efﬁcient induction of the Imd path-
way (109, 110). TCT provides an ideal “signa-
ture” of Gram-negative bacteria because this
muropeptide is located at the end of the PGN
strand and is released from PGN during cell
growth and division (Figure 4a). In contrast,
the minimum structure needed to activate the
Toll pathway is a muropeptide dimer of lysine-
type PGN (111).
PGRPs are highly conserved from insects
to mammals and share a 160 amino acid do-
main (the PGRP domain) with similarities to
bacteriophage T7 lysozyme, a zinc-dependent
N-acetylmuramoyl-l-alanine amidase (112–
114) (Figure 4b). Sequence analysis of the
13 Drosophila PGRPs points to the existence
of two subgroups with either recognition or
enzymatic properties. Members of the ﬁrst
group (PGRP-SA, SD, LA, LC, LD, LE,
and LF) lack zinc-binding residues required
for amidase activity but still retain the abil-
ity to bind and recognize PGN and function
as PRRs. In contrast, proteins from the other
subgroup of PGRPs, referred to as catalytic
PGRPs, have demonstrated (PGRP-SC1, LB,
SB1) or predicted (SC2, SB2) zinc-dependent
amidase activity that removes peptides from
the glycan chains, thereby reducing or elim-
inating the biological activity of PGN (115–
116a). Some of these PGRPs modulate the
immune response by scavenging PGN (115–
117). The tertiary structures of four PGRPs
have now been solved (118–123). A promi-
nent feature is the presence of an extended
surface groove in the PGRP domain, which
includes a zinc-ﬁnger cage in the catalytic
PGRP-LB. The structures of PGRP-LE and
PGRP-LCa/x in complex with TCT show an
interaction between the peptide stem of PGN
and the PGRP groove (Figure 4c). In contrast
to other PGRPs, the PGRP domain of PGRP-
LCa does not possess a typical PGN-docking
groove, in agreement with its role as a core-
ceptor sensing monomeric DAP-type PGN
(121).
Recognition of Gram-negative bacteria by
PGRP-LE/LC. PGRP-LC-deﬁcient ﬂies
display a strongly reduced expression of
antibacterial peptide genes in response to
Gram-negative bacteria. This effect is similar
to, albeit weaker than, that observed for imd-
deﬁcient mutants. Epistatic and phenotypic
analyses indicated that PGRP-LC is the
major receptor of the Imd pathway (59). Al-
ternative splicing of PGRP-LC can produce
three proteins (LCa, LCx, LCy) that share
the same intracellular (signaling) domain but
have distinct extracellular (sensing) domains
(109, 112). Studies in cell culture using RNAi
speciﬁc for each isoform have shown that
PGRP-LCx is required for recognition of
polymeric PGN, whereas both PGRP-LCa
and PGRP-LCx are mandatory for detection
of monomeric PGN (109). The current belief
is that signaling is achieved by association of
at least two PGRP-LC molecules in close
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Figure 4
Recognition upstream of the Toll and Imd pathways. (a) Structure of E. coli PGN. PGN is a complex
heteropolymer consisting of long glycan chains of alternating N-acetylglucosamine (GlcNAc) and
N-acetylmuramic acid (MurNAc) residues, connected by short peptide bridges (107). All the terminal
MurNAc residues ending the E. coli PGN glycan chains have a unique internal 1,6-anhydro bond. The
TCT monomer (indicated in blue) occurs naturally in Gram-negative bacteria at the extremity of all
glycan strands and is consequently present in approximately 5% of the GlcNAc-MurNAc units.
Lysosymes catalyze the cleavage of the β-1,4-glycosidic bond between the MurNAc and GlcNAc
residues (orange arrow) while amidase PGRPs remove the peptidic bridge from the sugar backbone (blue
arrow). (b) Schematic structure of some PGRPs and GNBPs. SP, signal peptide; TM, transmembrane
domain; PGRP, PGRP domain. GNPBs have an N-terminal domain that has been shown to bind
β(1,3)-glucan and a C-terminal domain with homology to glucanase. (c) Three-dimensional structure of
PGRP-LE with TCT (120). A prominent feature is the presence of an extended surface groove in the
PGRP domain that interacts with the peptide stem of TCT (in color).
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proximity through binding of polymeric
PGN. Such an interaction cannot occur
with monomeric PGN, and in this case
PGRP-LCa is expected to act as an adaptor
(121, 124). This model is supported by the
crystallization of TCT in complex with both
PGRP-LCa and LCx (122).
PGRP-LE encodes a PGRP with afﬁn-
ity to DAP-type PGN and is expressed both
extra- and intracellularly (125, 126). A frag-
ment of PGRP-LE corresponding to the
PGRP domain alone functions extracellularly
to enhance PGRP-LC-mediated PGN recog-
nition on the cell surface, a role evocative of
that of mammalian CD14 in binding of LPS to
TLR4 (127). A full-length form of PGRP-LE
is also present in the cytoplasm and acts as an
intracellular receptor for monomeric PGN,
thus bypassing the requirement for PGRP-
LC (127). Monomeric PGN probably gains
access to the cytoplasm by virtue of its small
size. Thus, both PGRP-LC and PGRP-LE
could participate in the sensing of Gram-
negative bacteria upstream of the Imd path-
way (Figure 3).
Downregulation of the Imd pathway by
amidase PGRPs. Injection of Gram-negative
bacteria induces a transient expression of an-
tibacterial peptide genes (Figure 3), suggest-
ing the existence of a mechanism to down-
regulate the immune response. Recent studies
in Drosophila revealed a key role for amidase
PGRPs in controlling the level of Imd path-
way activity by degrading PGN (116, 117).
PGRP-LB and PGRP-SC are efﬁcient ami-
dases that remove peptides from the glycan
chains and thereby convert Gram-negative
PGN into nonimmunostimulatory fragments.
PGRP-LB is active only on DAP-type PGN,
whereas PGRP-SC digests both DAP- and
Lys-type PGN (115, 116). RNAi extinction
of PGRP-SC1/2 or PGRP-LB leads to higher
Diptericin expression after systemic infection
compared to that of wild-type ﬂies. PGRP-LB
encodes a secreted protein and is regulated by
the Imd pathway. The presence of PGRP-LB
in the hemolymph establishes a negative feed-
back loop that ensures an appropriate degree
of immune activation in response to bacte-
rial infection (116). This mechanism econo-
mizes host resources by anticipating the ter-
mination of the immune response. Amidase
PGRPs may also prevent potentially severe
consequences to host tissues through pro-
longed immune activity. In agreement with
this idea, PGRP-SC1/2 RNAi larvae infected
with bacteria showed increased lethality asso-
ciated with developmental defects (117). The
Drosophila genome encodes four other cat-
alytic PGRPs. A combination of various ami-
dase PGRPs likely ensures an adequate degree
of immune reactivity in each ﬂy tissue.
Recognition of Gram-positive bacteria. A
mutation in PGRP-SA blocks the activation
of the Toll pathway by Gram-positive bacte-
ria but affects neither Toll activation by fungi
nor Imd pathway activation by Gram-negative
bacteria (128). PGRP-SA encodes a secreted
PGRP, which is present in the hemolymph
and acts upstream of Toll in the recog-
nition of Lys-type PGN of Gram-positive
bacteria (Figure 4b). Two additional pro-
teins, GNBP1 (Gram-negative Binding Pro-
tein, in fact a historical misnomer) and PGRP-
SD, have been implicated in the sensing of
Gram-positive bacteria. The immune pheno-
type of loss-of-function mutations in GNBP1
is indistinguishable from that of PGRP-SA
mutations, and experimental data indicate
that GNBP1 and PGRP-SA form a complex
in the hemolymph (129, 130). A proposed
function of GNBP1 would be to hydrolyze
Gram-positive PGN into small fragments
susceptible to detection by PGRP-SA (111,
130a). Some Gram-positive bacterial species
such as Staphylococcus aureus can activate the
Toll pathway in a PGRP-SA- and GNBP1-
independent manner, indicating that alter-
native receptors exist. Consistent with this
hypothesis, PGRP-SD, yet another secreted
PGRP, was found to mediate Toll activation
by a subset of Gram-positive bacteria, in par-
tial redundancy with the PGRP-SA/GNBP1
complex (131).
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Fungal recognition. Recent studies point to
a role of GNBP proteins in the detection
of fungal infection (81). Members of this
family display a signiﬁcant overall homology
to bacterial glucanases (131a) (Figure 4b).
They contain an N-terminal domain that
binds to β(1,3)-glucan and a C-terminal do-
main that is homologous to the catalytic do-
main of β-glucanase. However, the absence
of conserved key residues in the catalytic site
suggests that this domain is not functional.
The Drosophila genome contains three con-
sensus members of the GNBP family and
three related members containing only an
N-terminal domain similar to that of GNBP3.
The GNBP3 protein sequence is highly sim-
ilar to that of lepidopteran β Glucan Recog-
nition Proteins known to bind fungal β(1,3)-
glucans (131b). A role of GNBP3 in fungal
detection is supported by the observation that
GNBP3 mutants are sensitive to fungal in-
fection and fail to activate the Toll path-
way (131c). According to this observation,
GNBP3 is a circulating PRR acting upstream
of the Toll pathway in fungal detection.
Activation of Toll by serine proteases. The
Toll receptor is activated upon binding
of a cleaved form of Spa¨tzle (51, 52).
The immune-induced cleavage of Spa¨tzle is
thought to be triggered by secreted PRRs
that activate a proteolytic cascade, a process
conceptually similar to vertebrate blood co-
agulation or complement activation cascades
(132). These proteolytic cascades have a func-
tional core consisting of several serine pro-
teases (SPs) that undergo zymogen activation,
followed by cleavage of a substrate by the ter-
minal downstream protease. SP cascades al-
low the shaping and ampliﬁcation of extra-
cellular signals and are involved in complex
regulatory mechanisms, in which inappropri-
ate activation is prevented by the action of
SP inhibitors (serpins) (133). The Drosophila
genome encodes more than 200 SPs and ser-
ine protease homologs (SPHs), most of which
have as yet uncharacterized functions (134).
SPHs represent one quarter of all Drosophila
SP: serine protease
SPH: serine
protease homolog
SP-related proteins and are thought to pos-
sess regulatory functions (135, 136). Many
SPs that function in insect immunity contain
a Clip-domain N-terminal to the catalytic do-
main (137). This domain is only found in in-
sect SPs and is believed to play a regulatory
role in the sequential activation of SPs.
The activation of Spa¨tzle during the im-
mune response is achieved by a set of SPs
distinct from those mediating Toll activation
during embryonic development (44). Recent
studies demonstrate the existence of a com-
mon core of SPs and SPHs acting upstream
of Spa¨tzle in the immune response that inte-
grate signals sent by various secreted recogni-
tion molecules via more specialized SPs (138).
SPE, an immune-regulated Clip-domain SP,
has been identiﬁed as the Spa¨tzle processing
enzyme (138, 139). SPE presents 89% amino
acid identity with Easter, the enzyme that pro-
cesses Spa¨tzle in the embryo. Toll activation
by entomopathogenic fungi is independent of
PGRP-SA, but is mediated by an extracellu-
lar cascade involving the Clip-SP Persephone
(140) and the inhibitory serpin Necrotic (141).
Overexpression of persephone or loss of func-
tion of necrotic is sufﬁcient to trigger Spa¨tzle-
dependent activation of Toll in the absence of
an immune challenge.
Recognition: concluding remarks. The past
few years have seen the identiﬁcation of the
Drosophila PRRs regulating the Toll and Imd
pathways and of the microbial ligands that
they recognize. From an evolutionary point of
view, it is interesting to note that insects use
GNBPs and PGRPs as PRRs because these
are proteins derived from enzymes known to
degrade microbial cell wall products. Thus,
the roles of these molecules may have evolved
from microbicidal to recognition.
The organization of the Toll and the Imd
pathways differs, in that the former is acti-
vated by secreted PRRs whereas the latter
is activated through membrane-bound PRRs.
This difference of architecture could reﬂect
the mode of recognition: (a) direct for the
Toll pathway for which PRRs can bind to
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microbial ligands exposed at the surface of
Gram-positive bacteria and fungi, or (b) indi-
rect for the Imd pathway, which is activated by
PGN released from the periplasm of Gram-
negative bacteria.
Finally, it cannot be formally excluded
that these pathways are activated through the
recognition of host molecules (e.g., molecules
released at the wound site). The existence
of endogenous ligands is also supported by
the observation that larvae with melanotic tu-
mors display a signiﬁcant AMP gene expres-
sion level in the fat body in the absence of an
infection (142–144). One report suggests that
endogenous DNA can activate the Imd path-
way based on the observation that a ﬂy line de-
ﬁcient in DNase II exhibits a higher Diptericin
expression level in the absence of an infection
compared to that of wild-type ﬂies (145).
Epithelial Immunity in Drosophila
Because the barrier epithelia are in constant
contact with large numbers of microorgan-
isms, these surfaces must be armed with efﬁ-
cient systems for microbial recognition and
control. This is especially true for insects
such as Drosophila, which live on decaying
matter and feed on fermenting medium. In
Drosophila, both the gut and trachea, two main
routes of infection, are lined with a chitinous
matrix. Furthermore, the gut lumen is an en-
vironment hostile to microbial colonization
due to its physical and physiological proper-
ties and the secretion of lysozymes (146, 147).
In addition, local production of AMPs and
ROS provides two complementary inducible
defense mechanisms in the gut (Figure 5).
Local AMP expression. Expression of
AMPs has occasionally been reported in ep-
ithelia of other insect species. In the silkworm
larva Bombyx mori, Cecropin transcription is
induced in the epithelial cells underlying the
cuticle, when it is lightly abraded in the pres-
ence of live bacteria (148). In Drosophila, the
use of GFP reporter transgenes has revealed
that AMP genes are expressed in several
surface epithelia that are in contact with
the external environment (82, 149). These
include the epidermis, the reproductive sys-
tem, the respiratory tract, and the digestive
tract. This AMP synthesis is referred to
as the local immune response as opposed to
the systemic response. One can distinguish
between constitutive and inducible AMP
expression in epithelia. In the ﬁrst case,
the AMP gene is expressed constitutively
in a deﬁned tissue, and its transcription is
not upregulated during microbial infection.
This is the case for Drosomycin in salivary
glands and in the female spermatheca, and
for Cecropin in the male ejaculatory duct (82).
This constitutive expression is not regulated
by NF-κB pathways but by various tissue-
speciﬁc transcription factors such as the
homeobox-containing protein Caudal (150,
151). In virgin females, mating stimulates the
expression of some AMP genes (152).
The second form is the inducible lo-
cal AMP gene expression. This response is
triggered upon natural infection by Gram-
negative bacteria and is mediated by the Imd
pathway (82, 153). For example, Drosomycin
and Diptericin are induced in both trachea and
gut via the Imd pathway in response to lo-
cal infection by bacteria such as Erwinia caro-
tovora (154). Like the systemic response, the
local immune response is mediated through
the recognition of Gram-negative PGN by
PGRP-LC (116). It remains to be clariﬁed
why commensal bacteria or ingested PGN
does not generate a state of permanent im-
mune activation in tissues such as the gut.
A central role in bacterial tolerance of the
gut has been attributed to amidase PGRPs,
as they scavenge PGN released by commen-
sals (116, 117) (Figure 5). Because Gram-
negative PGN is hidden in the periplasmic
space underneath the outer LPS membrane
and bacteria residing in the gut have a low
division rate, commensals may well release
only low amounts of PGN that can readily
be hydrolyzed by amidase PGRPs. This im-
plies the important concept of a threshold re-
sponse for local immune activation in order to
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ROS
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Figure 5
Gut immune response. Local production of ROS (left) and AMPs (right) provides two inducible defense
mechanisms in the gut. ROS are produced by the Duox protein and are detoxiﬁed by the IRC catalase
(156–158). Enzymatic assays demonstrated that the PHD domain of Drosophila DUOX can transform
H2O2 into the highly microbicidal HOCl. AMPs (e.g., Diptericin or Attacin) are produced by epithelial
cells under the control of the Imd pathway upon recognition of PGN released by Gram-negative bacteria
(116, 117). Amidase PGRPs degrade PGN in nonimmunostimulatory fragments, thereby reducing the
gut immune reactivity. Bacteria such as Pseudomonas entomophila secrete an abundant protease (AprA) that
degrades AMPs (238). PM, peritrophic matrix.
differentiate between commensal microor-
ganisms and invading pathogens.
To date, no implication of the Toll path-
way in the local immune response has been
demonstrated, and there is no evidence that
AMPs are induced in epithelia in response to
Lys-type Gram-positive bacteria or fungi.
ROS production. In mammals an immedi-
ate epithelial response to pathogen assault is
the generation of ROS. In Drosophila, natural
infections with bacteria also induce rapid ROS
synthesis in the gut, and the dynamic cycle of
ROS generation and elimination appears to
be vital.
The Duox proteins form a conserved fam-
ily of molecules that contain, in addition to the
NADPH domain, an N-terminal extracellular
peroxidase domain (PHD) that can produce
ROS in a regulated manner (155). Inactivation
of the Duox gene by RNAi blocks ROS pro-
duction in the gut of infected ﬂies, suggesting
that this enzyme is the sole source of epithelial
ROS (156). Duox RNAi ﬂies rapidly succumb
to oral infection by the Gram-negative bacte-
ria E. carotovora, and this lethality is associated
with an inability to control bacterial growth.
Excessive ROS production, which is delete-
rious to the host, is prevented in Drosophila
by immune responsive catalase (IRC). Silenc-
ing of IRC by RNAi results in higher ROS
production and ﬂy lethality, indicating that
IRC provides an antioxidant defense system
in Drosophila (157). The IRC and Duox phe-
notypes demonstrate that a ﬁne redox balance
www.annualreviews.org • Host Defense of Drosophila melanogaster 711
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
Figure 6
Drosophila hematopoiesis and hemocyte functions. The lymph gland contains a large number of
hemocyte progenitors that can differentiate into three hemocyte types with distinct functions (indicated
on the right). Many factors that regulate key steps of hematopoietic lineage commitment have been
identiﬁed: serpent (GATA factor), U-shaped (Friend-of-GATA), Lozenge (Runx1 homolog), Glial Cells
Missing 1 and 2, PVR (homologous to RTK receptors), and Collier (EBF ortholog) (164, 165, 193).
Given their similarities to mammalian hematopoietic factors, these studies point to a conservation of
molecular bases for blood-lineage determination in mammalian and Drosophila hematopoiesis. The
JAK-STAT, Ras/Raf/MAPK, and Toll signaling pathways have also been implicated in hemocyte
differentiation and proliferation, but their exact function is not yet known (276, 277).
is critical for control of microorganisms in the
gut lumen. This ROS-dependent gut immu-
nity is not affected by the Imd pathway and
provides an additional barrier against ingested
microorganisms (158) (Figure 5).
Cellular Response
The body cavity of Drosophila, like that of
all arthropods, is ﬁlled with a circulating
hemolymph that contains both free-ﬂoating
and sessile blood cells (hemocytes). Drosophila
larvae contain several thousand hemocytes,
which can be divided into the following three
cell types on the basis of their structural
and functional features: plasmatocytes, crys-
tal cells, and lamellocytes (Figure 6) (159,
160). Plasmatocytes represent 90%–95% of
all mature larval hemocytes and function in
the phagocytic removal of dead cells and mi-
crobial pathogens. Lamellocytes are relatively
large, ﬂat, and adherent cells that primar-
ily function in encapsulation and neutraliza-
tion of objects too large to be phagocytosed.
Lamellocytes are not found in embryos and
adults, and they are rarely observed in healthy
larvae, although large numbers of these cells
can be induced to differentiate from hemocyte
precursors upon infection of larvae with par-
asitoid wasp eggs. Crystal cells constitute 5%
of the larval hemocytes and are nonphagocytic
cells involved in the melanization process.
Mature crystal cells express proPOs, which
are oxidoreductases related to hemocyanins
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and which mediate melanization. They are
fragile, readily disrupt, and release their con-
tents into the hemolymph upon activation.
They thus function as storage cells for the
large amounts of proPO present in their cy-
toplasm in crystallized form (161).
Hematopoiesis. In Drosophila, mature plas-
matocytes arise from two spatially and tem-
porally distinct phases of hematopoietic de-
velopment, one early in the embryonic head
mesoderm and another during larval develop-
ment in a specialized organ called the lymph
gland (162–166). The embryonic phase of
hematopoiesis gives rise to the mature cir-
culating hemocytes of larval stages whereas
lymph gland plasmatocytes, under normal,
nonimmune conditions, do not enter circu-
lation until metamorphosis. At the onset of
metamorphosis, the lymph gland releases a
large number of actively phagocytosing plas-
matocytes, called pupal macrophages, which
play a critical role in tissue remodeling as they
phagocytose doomed larval cells. Once in cir-
culation, these lymph gland–derived hemo-
cytes, along with a subset of hemocytes de-
rived from embryonic cells, persist into the
adult stage. Many factors that regulate hemo-
cyte differentiation and development have
been investigated both at embryonic and lar-
val stages (164, 165) (Figure 6). Recent stud-
ies have revealed that the primary lymph
gland lobes are compartmentalized into three
distinct zones: a posterior signaling center
that acts as an organizer, a medullary zone
containing hemocyte precursors, and a cor-
tical zone containing differentiating hemo-
cytes (Figure 6) (167, 168). The posterior
secondary lobes serve as a reservoir for pro-
hemocytes in a semiquiescent phase, but have
a less well-deﬁned organization than the pri-
mary lobes. Hemocyte proliferation is ob-
served mostly in the cortical zone of the lymph
gland and is barely detected among circulat-
ing cells. Both proliferation and differentia-
tion can be modulated by developmental and
immune stimuli. In the adults, lymph glands
are absent and no hemocyte proliferation is
dsRNA:
double-stranded
RNA
observed, leaving a uniform population of sev-
eral thousand mature plasmatocytes.
Blood cell immune functions. Phagocyto-
sis and encapsulation are two major mecha-
nisms of the cellular response.
Phagocytosis. In Drosophila, plasmatocytes
are responsible for the disposal of both mi-
croorganisms and apoptotic cells. They can
internalize a large variety of particles such
as bacteria, yeast, Sephadex beads, double-
stranded RNA (dsRNA), or ink particles
within minutes. The ﬁrst step of phagocytosis
is the attachment of the phagocyte to the tar-
geted particle, followed by cytoskeleton mod-
iﬁcation, internalization, and destruction of
the engulfed target within phagosomes.
To date, phagocytosis has been shown to
involve several types of receptor proteins.
These include members of the scavenger re-
ceptor family (dSR-CI), the EGF-domain
protein Eater, and the IgSF-domain protein
Dscam (169–172). Proteins related to CD36
appear to favor phagocytosis, and two reports
have proposed that PGRP family members
could also play a role in this process (61,
173, 174). The immune role of phagocyto-
sis receptors is particularly well documented
in the case of Eater, which is expressed exclu-
sively on plasmatocytes (and prohemocytes)
where it binds to and helps to internalize a
broad range of bacteria (171). Importantly,
Eater-deﬁcient ﬂies show a severe reduction
of phagocytosis of Gram-negative and Gram-
positive bacteria. An LPS recognition pro-
tein (LRP) with six EGF repeats was recently
identiﬁed in the beetle Holotrichia diomphalia
(175). LRP is a protein that is secreted into the
hemolymph and aggregates Gram-negative
bacteria through its association with LPS.
This points to the role of EGF-like repeat-
containing proteins to phagocytose and ag-
gregate bacteria in insects.
The existence of entry receptors speciﬁc
for certain pathogens is supported by the
observation that knock-down of pestes, a
member of the CD36 family of scavenger
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TEP:
thioester-containing
protein
receptors, blocks entry of M. fortuitum and L.
monocytogenes in S2 cells, whereas it does not
affect uptake of E. coli or S. aureus (176).
Another receptor that binds microor-
ganisms and participates in phagocytosis is
Dscam. It encodes a member of the Ig su-
perfamily with essential function in neuron
interconnection (172). The Dscam gene com-
prises a cluster of variable exons ﬂanked by
constant exons, which can theoretically gen-
erate by alternative splicing as many as 19,000
isoforms. Secreted isoforms of Dscam were
detected in the hemolymph, and hemocyte-
speciﬁc Dscam silencing reduces the phago-
cytic uptake of bacteria. The molecular diver-
sity of Dscam transcripts is highly conserved
across major insect orders, pointing to a con-
served role of this gene.
Systematic RNAi screens in S2 cells identi-
ﬁed many Drosophila genes required for the in-
ternalization of various microorganisms (61,
176–179). As expected, a large number of
these genes affect actin cytoskeleton organi-
zation (cdc42, Arp2/3complex, actin capping
proteins, coﬁlin) and vesicle trafﬁcking as well
as other essential cell functions. Among the
rare in vivo studies, a genetic analysis has
clearly demonstrated a role for the WASp ho-
molog D-Scar in phagocytosis, while Chick-
adee, the Drosophila homolog of the G-actin
sequestering protein Proﬁlin, negatively reg-
ulates this process (180). The observation that
phagocytosis was only reduced by 40% in D-
Scar ﬂies underlines the complexity of the
phagocytosis process, and the possibility that
multiple internalization pathways coexist in
Drosophila hemocytes.
In mammals, the engulfed target is de-
stroyed within phagosomes by lysosomal
enzymes, ROS, and nitric oxide as well as
antimicrobial factors such as defensins. The
mechanisms that kill the microorganisms in-
side the vacuoles have been poorly inves-
tigated in Drosophila. DNase II enzymes
are highly conserved proteins that are re-
quired for the degradation of DNA within
phagolysosomes. Flies depleted in DNase II
show an increased susceptibility to infection
with both Gram-positive and Gram-negative
bacteria, although this phenotype could not
be deﬁnitely linked to a phagocytosis defect
(181).
Opsonization. The Drosophila genome har-
bors six genes coding for proteins struc-
turally related to the complement alpha2-
macroglobulin family (88). Five of these genes
contain a canonical thioester motif and are
referred to as thioester-containing proteins
(TEP1 to TEP5); the sixth member, TEP6
or Mcr (Macroglobulin-complement related),
lacks the cystein residue that forms the char-
acteristic thioester of TEPs. The TEP fam-
ily members possess a signal peptide indi-
cating that they are secreted, and three of
them, TEP1, TEP2, and TEP4, are upreg-
ulated upon infection (88). It has been pro-
posed that TEPs function during the immune
response as opsonins to promote phagocy-
tosis and/or protease inhibitors. An opsonin
function for a TEP member has been docu-
mented in Anopheles gambiae where TEP1 is
also involved in parasite killing of Plasmodium
(182). Recently, the contribution of Drosophila
TEPs to phagocytosis has been investigated in
S2 cells using RNAi (178). TEP2 and TEP3
are required for efﬁcient phagocytosis of the
Gram-negative bacteria E. coli and the Gram-
positive bacteria Staphylococcus aureus, respec-
tively, and Mcr for successful binding to the
surface of C. albicans and for efﬁcient inter-
nalization of this fungus. Other opsonization
factors could be secreted isoforms of Dscam
or so far uncharacterized proteins related to
the LRP of H. diomphalia.
Encapsulation. Encapsulation is a dramatic
defense reaction against invading parasites
that is mediated by lamellocytes in Drosophila
larvae. The encapsulation reaction has es-
sentially been analyzed using wasps that lay
their eggs into the hemocoel of larvae, but
it can also be induced by the injection of an
oil droplet (Figure 6, and see Figure 8b,c)
(165, 183). The wasp egg is detected by plas-
matocytes, which exert a permanent immune
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surveillance in circulation (184). They attach
to the egg chorion and induce within a few
hours, through unknown signaling molecules,
a strong cellular reaction in the lymph gland,
with an increase in proliferation and the mas-
sive differentiation of lamellocytes from pro-
hemocytes of the medullary zone and sec-
ondary lobes (168). Lamellocytes are released
from the lymph gland and then form a multi-
layered capsule around the invader, a process
that is ultimately accompanied by blackening
of the capsule due to melanization. Within
the capsule, the parasite is eventually killed,
possibly by the local production of cytotoxic
products such as ROS and intermediates of
the melanization cascade (185), but the ex-
act cause of death is not known. The molecu-
lar mechanisms underlying the whole process
of encapsulation are virtually unknown. Use
of thermosensitive alleles of the myospheroid
gene, which encodes an integrin subunit, re-
duced the efﬁciency of capsule formation
without affecting lamellocyte differentiation.
A role for integrins in this process is not un-
expected as lamellocytes aggregate and stick
together through septate junctions in order
to build a capsule (186). This is further sup-
ported by studies in Lepidoptera (187). Two
members of the Rho GTPase family, Rac1
and Rac2, which regulate many aspects of cy-
toskeleton remodeling, have also been shown
to participate in this process. In Rac2 mu-
tants, plasmatocytes adhere to the parasitoid
egg but fail to spread, and septate junctions
do not assemble, possibly due to defective lo-
calization of the Protein 4.1 homolog Coracle
(188). Rac1 and the Jun Kinase Basket regu-
late the formation of actin- and focal adhesion
kinase (FAK)-rich placodes in hemocytes and
are both required for the proper encapsula-
tion of parasitoid wasp eggs (189). Hemese
is a transmembrane glycophorin-like protein
with an expression restricted to the cell sur-
face of hemocytes and to the hematopoietic
organs (190). Depletion of Hemese by RNAi
has no obvious effect under normal condi-
tions, but the cellular response to parasitic
wasps is much enhanced, suggesting a mod-
ulatory role in the activation or recruitment
of hemocytes. Microarray analysis identiﬁed
many genes whose expression is upregulated
after wasp infection. These genes are promis-
ing candidates for the analysis of the encapsu-
lation process (191).
Encapsulation is a fascinating immune re-
action that requires communication between
distant organs and involves different hemo-
cyte lineages. The mechanism by which the
wasp eggs are recognized by the Drosophila
immune system is not known. Since para-
sitoids and Drosophila are phylogenetically re-
lated, wasp eggs may not be easily detected
through PRRs in contrast to fungi or bacte-
ria. Early experiments showed that Drosophila
larvae encapsulate transplanted tissues from
the same species when they are mechanically
damaged. Tissue fragments with intact base-
ment membrane remain free in circulation
(192). This suggests that the destruction of the
basement membrane is sufﬁcient to induce an
encapsulation reaction. Hemocytes could rec-
ognize intruders due to the absence of a factor
found on their own basement membrane. A
further question is the nature of the signaling
molecules that trigger lamellocyte differenti-
ation within the lymph gland. An attractive
hypothesis holds that upon sensing the wasp
egg, plasmatocytes send a cytokine to the pos-
terior signaling center in the lymph gland to
induce lamellocyte speciﬁcation in neighbor-
ing cells (193).
Melanotic pseudotumors. The melanotic
pseudotumor—or melanotic tumor—pheno-
type is characterized by the presence of black
bodies either free-ﬂoating within the body
cavity, or attached to internal organs (194,
194a). These noninvasive pseudotumors are
rare in wild-type ﬂies but can be frequent
in some genetic backgrounds. Melanotic
capsules share many features with capsules
that form around a parasite, as they contain
layers of melanized lamellocytes. Watson has
proposed a distinction between two types
of melanotic tumor mutants (195). Class 1
includes mutants in which melanotic tumors
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result from an “autoimmune response” or the
response of an apparently normal immune
system to an abnormal target tissue. It was
proposed that disruption of the basement
membrane that lines tissues could lead to
melanotic tumors by inducing hemocyte
adhesion and capsule formation (192). Class 2
mutants display overactivation of hemocytes
resulting in the formation of capsules. Many
mutations known to activate the ﬂy immune
system (such as Toll and JAK gain-of-function
mutations) belong to this class (142, 196).
Other hemocyte immune functions. Like the
fat body, hemocytes store various molecules
that can be released upon infection. Plasma-
tocytes express immune molecules such as the
blood clotting factor Hemolectin or the Toll
ligand Spa¨tzle, whereas crystal cells contain
the enzymes required for the melanization
cascade (161, 186, 197). Circulating plasma-
tocytes express many components of the ex-
tracellular matrix (Collagen IV, Peroxidasin,
etc.) and may contribute to the formation of
basal membranes (198).
Septic injury also triggers the expression of
antibacterial peptide genes via the Imd path-
way in a subset of circulating plasmatocytes
(199). Their contribution to hemolymph an-
timicrobial activity is probably minimal. Both
S2 and mbn-2 cell lines that derive from
hemocytes express AMP genes in the presence
of Gram-negative PGN and Drosomycin in re-
sponse to Spa¨tzle (43, 110, 200). In these cells,
the Imd pathway also activates the JNK path-
way that may participate in hemocyte acti-
vation through cytoskeleton remodeling (21,
96).
Hemocytes are believed to play sig-
naling functions between distant immune-
responsive tissues, in particular via the pro-
duction of cytokines (e.g., Upd-3) (89).
COAGULATION AND
MELANIZATION
Physical breakage of the arthropod cuticle im-
mediately induces hemolymph clotting and
melanization. Although these reactions are
well characterized in other arthropods (201,
202), progress in our understanding of these
reactions in Drosophila has been made only
recently.
Coagulation
Clotting is critical in limiting hemolymph loss
and initiating wound healing in insects as in
vertebrates. It is also an important immune
defense, quickly forming a secondary bar-
rier to infection, immobilizing bacteria and
thereby promoting their killing. In Drosophila
larvae, a clot composed of ﬁbers trapping
hemocytes is rapidly generated at the site of
injury (Figure 7a,c). This reaction is inde-
pendent of melanization because it still oc-
curs in proPO-deﬁcient mutants (see below)
(203). It is, however, assumed that cross-
linking enzymes, including proPO itself and
transglutaminase, may be involved in hard-
ening of clots (204, 205). Subsequent steps
in wound closure include melanization and
epithelial movements (Figure 7c) (92, 93).
One plasmatocyte-speciﬁc gene, hemolectin,
has been demonstrated to be required for ef-
ﬁcient clot formation in Drosophila (197, 203).
Hemolectin is a large protein with several
domains that are also present in other clot-
ting factors (Figure 7b). It is a major com-
ponent of the ﬁbers (Figure 7b). A pull-
down assay and proteomic studies have iden-
tiﬁed additional proteins present in the clot
(203, 204). One of these, Fondue, is an abun-
dant hemolymph protein regulated by the
Toll pathway, which exhibits multiple repeat
blocks. Depletion of fondue by RNAi in-
duced clotting defects (144). Fondue is not in-
volved in the formation of primary clot ﬁbers,
but rather in the subsequent cross-linking
of these ﬁbers. Wounding of fondue-RNAi
or hemolectin larvae or ﬂies does not lead to
increased mortality compared to challenged
controls. Thus it appears that impairment of
clotting in vivo leads to more subtle pheno-
types, such as the formation of larger scabs
(144, 203).
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Figure 7
Clotting reaction in Drosophila. (a) A Drosophila clot with ﬁbers and incorporated plasmatocytes.
(Courtesy of Ulrich Theopold, Stockholm University.) (b) Structure of Hemolectin. Hemolectin is a
large protein with domains that are also present in other clotting factors (197). Hemolectin is a major
component of Drosophila clotting ﬁbers. This ﬁgure was done using the SMART bioinformatic tool
(EMBL, Heidelberg) for identiﬁcations and positions of domains. (c) A model for clot formation at an
injury site. Upon injury, plasmatocytes immediately release Hemolectin and other proteins that form clot
ﬁbers. Cross-linkage of these ﬁbers occurs with the help of proteins such as Fondue, transglutaminase,
and proPO, the latter being released by crystal cells.
Melanization
An immediate immune response in Drosophila
is the melanization reaction observed at the
site of cuticular injury or on the surface of
parasites invading the hemocoel (Figure 6).
This blackening reaction results from the de
novo synthesis and deposition of melanin. It
is generally assumed that melanization plays
an important role in arthropod defense re-
actions such as wound healing, encapsula-
tion, sequestration of microorganisms, and
the production of toxic intermediates that
are speculated to kill invading microorgan-
isms (206–208). Melanization requires the ac-
tivation of proPO, an enzyme that catalyzes
PO: phenoloxidase
PPAE:
prophenoloxidase
activating enzyme
the oxidation of mono- and diphenols to
orthoquinones, which polymerize nonenzy-
matically to melanin. Enzymatically inactive
proPO is cleaved into active phenoloxidase
(PO) by an SP known as prophenoloxidase ac-
tivating enzyme (PPAE). PPAE also exists as
an inactive zymogen that is itself stimulated
through a stepwise process involving other
SPs. Studies with other insect species indicate
that the melanization cascade is triggered by
injury or by recognition through PRRs of mi-
crobial ligands, such as PGN, β(1,3)-glucan,
and LPS (209–212). Consequently, the proPO
cascade is an efﬁcient nonself-recognition sys-
tem in invertebrates.
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The Drosophila genome encodes three pro-
POs: DoxA1, DoxA3, and CG8193. DoxA1
and CG8193 are expressed in crystal cells
while DoxA3 is exclusively expressed in lamel-
locytes and as a consequence may participate
in melanization during encapsulation (186).
Melanization at injury sites in larvae is me-
diated exclusively by crystal cells and is im-
paired in three classical hemocyte mutants:
domino, which lacks hemocytes (213); Black
cells, which has aberrant crystal cells; and
lozenge, which lacks crystal cells (161). None
of the classical immune pathways (Toll, Imd,
JAK-STAT) is involved in the rapid release of
PO by crystal cells, but the rupture of crystal
cells and subsequent melanization are blocked
when the function of the RhoA GTPase is al-
tered (81). The source of PO in adults that
are devoid of crystal cells is not known. Re-
cently, two Clip domain-containing SPs, MP1
and the crystal cell-speciﬁc MP2/sp7/PAE,
and one serpin, Serpin27A, have been im-
plicated in the melanization cascade (143,
214–217). Inactivation of MP1 and MP2 re-
duces the level of PO activity after immune
challenge, while excessive melanization is ob-
served in Serpin27A-deﬁcient mutants. The
role of Serpin27A is to restrict melanization
to the site of injury and prevent systemic
melanization. These analyses also suggest that
MP1 is involved in the defense against both
bacteria and fungi, whereas MP2 is more spe-
ciﬁc for the antifungal response (217). Except
for these reports, our information on the orga-
nization of proteolytic cascades that regulate
proPO activation is still scarce, and a possible
link with PRRs remains to be established.
DROSOPHILA IMMUNITY AND
PATHOGEN EVASION
STRATEGIES
Immune defense mechanisms are selected for
their capacity to confer resistance to microor-
ganisms and parasites encountered in the wild.
Their organization somehow reﬂects the evo-
lution of interactions between the host and
its pathogens. It is therefore important to un-
derstand how an immune system works in re-
sponse to its pathogens and the diseases they
inﬂict on the host. A major difﬁculty for a de-
tailed understanding of the ﬂy immune sys-
tem is our ignorance of the impact of vari-
ous pathogens on Drosophila populations. This
situation is complicated by the fact that D.
melanogaster belongs to a fruit ﬂy species that
recently spread across the world and is often
associated with human habitats. This broad
ecological niche does not help to narrow down
the list of natural Drosophila pathogens and
their effects. However, a number of Drosophila
pathogens have been identiﬁed in laboratories
or in the wild (218), some of which are cur-
rently used to analyze the immune response
under more physiological conditions.
In the second section of this review, we
ﬁrst describe various infection models used
to study Drosophila immunity and then discuss
the evasion strategies developed by pathogens
to escape the immune response, thereby re-
vealing the complexity of host pathogen in-
teractions in an insect model.
Immunity to Bacteria
Immunity to septic injury. Our knowledge
of the Drosophila immune response is essen-
tially based on the analysis of host reactions
following injection of nonpathogenic bacte-
ria (e.g., E. coli or Micrococcus luteus) either by
pricking the body wall with a sharp needle
coated with bacteria or by the microinjection
of a precise dose of microbes directly into the
body cavity of the insect. As discussed above,
directly introducing a microorganism into the
hemocoel triggers a rapid response that allows
monitoring of the multiple facets of the in-
teractions between a microorganism and the
systemic immune defense (219). The expres-
sion of AMP genes is usually proportional to
the number of bacteria injected and reaches
a plateau or even decreases when ﬂies are in-
jected with massive doses of bacteria (108).
There is no equivalent of an overactive in-
ﬂammatory response in adult Drosophila com-
parable to the septic shock in mammals, and
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ﬂies are resistant to injection of large amounts
of bacteria such as E. coli.
Mutations affecting the Imd or the Toll
pathways cause the most severe immune de-
ﬁciency to bacterial challenge, and death
is always associated with excessive bacterial
growth (44). Death of the host usually oc-
curs when numbers of bacteria increase be-
yond 106 per ﬂy. Inhibition of phagocytosis
through injection of Sephadex beads that sat-
urate the plasmatocytes has no effect in wild-
type adults but increases the susceptibility of
imd mutant ﬂies to E. coli (220). Similarly, an
effect of melanization against bacteria can be
detected when a mutation affecting this pro-
cess is combined with Toll or Imd pathway
mutations (55, 217). Survival experiments in
larvae carrying combinations of mutations af-
fecting hemocytes (domino), the antibacterial
response (imd), and melanization (Black cells)
after an immune challenge with E. coli estab-
lish the relevance of all three immune reac-
tions in larvae—AMP production, phagocyto-
sis, and melanization—and point to a synergy
between them to ﬁght infection (213).
Two fast killers: Pseudomonas aeruginosa
and Serratia marcescens. Unlike the situa-
tion described above, injection of a small num-
ber of cells of Pseudomonas aeruginosa or Ser-
ratia marcescens into the hemolymph is fatal
to wild-type ﬂies (7, 221–223). Both bacte-
ria are opportunistic and versatile pathogens
that have developed the ability to adapt to
a large number of environmental conditions.
The reasons why these two bacterial species
are so pathogenic to ﬂies are not clearly estab-
lished. Following injection, P. aeruginosa in-
vades and degrades ﬂy tissues and uses them
as a nutrient source (224). A prior injection
with nonpathogenic variants partially protects
against a subsequent infection by P. aeruginosa,
and this effect is Toll- and Imd-dependent.
Mutants deﬁcient for Toll and Imd pathways
are more susceptible to P. aeruginosa than are
wild-type ﬂies (224, 225). This indicates that
P. aeruginosa is somewhat sensitive to the ﬂy
humoral response, but can ultimately over-
come it. A microarray analysis indicated that
AMP gene expression is delayed when ﬂies
are challenged with a pathogenic strain of P.
aeruginosa as compared to nonpathogenic bac-
teria (225). Altogether these data point to the
existence of a complex set of strategies used
by P. aeruginosa to suppress and escape the im-
mune response.
Many P. aeruginosa mutants with decreased
pathogenicity have been identiﬁed, but none
of these mutations leads to a complete loss
of virulence (219, 221, 226). Toxins such as
phenazine and pyoverdine, as well as injection
of virulence factors into host cells through
the Type III secretion system, participate in
virulence. A recent study indicates that P.
aeruginosa suppresses its own phagocytosis by
Drosophila hemocytes through the injection,
via the Type III apparatus, of a Rho-GAP
GTPase toxin that impairs hemocyte function
(227, 228).
Two slow killers: Mycobacterium mar-
inum and Salmonella typhimurium. My-
cobacterium marinum, a pathogenic bacterium
closely related to M. tuberculosis, causes a
tuberculosis-like disease in ﬁsh and frogs. It
is lethal to ﬂies within 8 days following injec-
tion of a low dose (229). M. marinum initially
proliferates inside plasmatocytes and spreads
later in the course of infection to the whole or-
ganism. Intracellular M. marinum blocks vac-
uolar acidiﬁcation, suggesting that it success-
fully subverts ﬂy plasmatocytes as it does with
vertebrate macrophages. Consistent with an
intracellular localization of this bacterium, in-
jection of M. marinum does not trigger AMP
gene expression and as a consequence imd and
Toll mutant ﬂies do not exhibit higher sus-
ceptibility than wild-type ﬂies. Flies infected
with M. marinum progressively lose energy
reserves, and this wasting-like process partic-
ipates in the pathogenesis (229a).
Similarly, injection of Salmonella ty-
phimurium causes death within 7–9 days.
Bacterial growth in the hemolymph is limited
by the Imd pathway (230). Like M. marinum,
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Ecc15: Erwinia
carotovora 15
this bacterium survives in hemocytes and im-
pairs their function, leading to slow death.
Although M. marinum and S. typhimurium
are not true Drosophila pathogens, these stud-
ies suggest that one mechanism used by bac-
teria to resist the systemic immune response
is to reside inside hemocytes and to alter their
phagocytic function, similar to intracellular
pathogens in vertebrates.
Drosophila as a model host to identify bacte-
rial virulence factors. The good correlation
between virulence factors of P. aeruginosa re-
quired to infect Drosophila and those required
to infect vertebrates, as well as the observation
that many human pathogenic bacteria have a
broad host range including invertebrates, has
launched the use of D. melanogaster and C. ele-
gans as alternative model hosts (219, 231, 232).
Indeed, several studies suggest that Drosophila
can be used to screen for virulence factors
and to analyze the complex interactions be-
tween pathogenic bacteria and the innate host
defense (219, 221–230, 233–234). Recently,
high-throughput RNAi screens in S2 cells
have been developed to systematically screen
for host components required for bacterial in-
ternalization and spreading. Such large-scale
screens have been applied to L. monocytogenes,
Legionella pneumophila, and Mycobacterium
fortuitum (176–179, 233, 234).
Even though the requirement for some vir-
ulence factors depends on a speciﬁc host, in-
vertebrate models may now provide a pow-
erful tool to reveal new aspects of bacterial
pathogenesis.
Immunity after oral bacterial infection.
Injuries are probably not a frequent source of
entry of pathogens in Drosophila, unlike oral
infection upon ingestion. One limitation of
approaches using injection is that they bypass
the initial steps of naturally occurring infec-
tions including bacterial colonization, persis-
tence, and the host local immune response. In
addition, the microorganisms generally used
are not true pathogens of Drosophila. To over-
come this limitation, the use of natural oral
infections with infectious bacteria has been
developed.
Flora and bacterial pathogens of
Drosophila. Drosophila ﬂies live on fer-
menting medium and as a consequence their
gut ﬂora will reﬂect bacteria living in their
food (218). It is not clear whether a stable gut
ﬂora exists in this insect. The study of ﬂies
raised axenically (deprived of their normal
ﬂora) points to a contribution of this ﬂora
to the physiology of these insects (218). To
date, the inﬂuence of this natural gut ﬂora on
the Drosophila immune system has not been
investigated.
Fruit ﬂies have been involved in the trans-
mission of many phytopathogenic bacteria
and probably participate in their dissemina-
tion in the environment (218). Recently, a
few bacterial strains were found to be able to
trigger an immune response in ﬂies or to be
pathogenic after oral infection. These include
S. marcescens Db11, Erwinia carotovora 15
(Ecc15), and Pseudomonas entomophila. These
bacteria can establish a persistent interaction
with their host.
S. marcescens Db11. S. marcescens Db11 was
isolated from moribund ﬂies in the labora-
tory (222). Oral infection by S. marcescens
kills ﬂies within 4 to 8 days. This bacterium
persists in the gut where it triggers local
AMP gene expression and crosses the in-
testinal barrier to reach the hemocoel with-
out, however, eliciting a systemic immune
response (81). S. marcescens may not be de-
tected by the ﬂy immune system as a result of
a low release of PGN into the hemolymph.
Two host defense mechanisms contribute to
host survival against S. marcescens: (a) local
AMP expression in the gut and (b) phagocy-
tosis of S. marcescens in the hemolymph (81,
171).
Erwinia carotovora 15 (Ecc15). A Gram-
negative bacterial strain, Ecc15, was initially
identiﬁed for its capacity to persist in the
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Drosophila gut and to trigger both local and
systemic immune responses following oral in-
fection (82, 154). Both responses are mediated
by the Imd pathway. E. carotovora are phy-
topathogenic bacteria that cause soft rot in
fruit and use insects as vectors. Ecc15 persists
in the gut of larvae while not killing them.
This effect is mediated by a single gene, Er-
winia virulence factor (Evf ) (235). Evf plays a
direct role in gut persistence as its transfer into
other Gram-negative bacteria enables them
to persist in the Drosophila gut and to elicit
a systemic immune response (236). Evf en-
codes a novel protein with no homology in
the databases. The exact mechanism by which
Evf promotes bacterial persistence in the gut
is not known. That Evf is found only in a sub-
set of E. carotovora strains that have infectious
properties toward Drosophila suggests that it
is an example of a gene that promotes sur-
vival and dissemination of bacteria in their
environment.
P. entomophila. P. entomophila is a novel
Pseudomonas species collected from a ﬂy in
Guadeloupe (237). In contrast to Ecc15, P. en-
tomophila is highly pathogenic for Drosophila as
well as for other insect species by destroying
the gut. In addition, this bacterium induces a
food-uptake blockage in Drosophila larvae. Al-
though P. entomophila triggers both local and
systemic activation of the Imd pathway, only
the gut antimicrobial response contributes to
host survival after oral infection (238). One
mechanism used by P. entomophila to coun-
teract the gut immune response is the secre-
tion of an abundant protease, AprA, that de-
grades AMPs produced by gut epithelia and
thereby promotes bacterial persistence (238).
S. marcescens also expresses a protease (222).
Taken together, these results suggest that pro-
teases may represent a common strategy used
by pathogens to circumvent the local antimi-
crobial host defense of insects (Figure 5).
Many pseudomonads and other bacteria ex-
press proteases similar to AprA but are not
able to infect Drosophila by oral ingestion.
This indicates that P. entomophila virulence is
multifactorial, AprA being one virulence fac-
tor among others. The complete sequencing
of the P. entomophila genome has revealed the
existence of large sets of genes encoding pu-
tative virulence factors such as proteases, li-
pases, toxins, and proteins involved in alginate
synthesis (239).
Gut infection and fat body immune re-
sponse. Both Ecc15 and P. entomophila can
trigger a strong systemic immune response
in Drosophila after oral infection, pointing to
the existence of a signaling mechanism from
the gut to the fat body. This immune re-
sponse correlates with the capacity of these
bacterial species to persist and multiply in-
side the gut and does not appear to rely on
physical crossing of the gut wall (236, 237).
It has been proposed that this systemic im-
mune response is mediated by the transloca-
tion of small PGN fragments from the gut
lumen to the hemolymph (116). This view is
supported by the observation that ingestion of
monomeric PGN can stimulate a strong sys-
temic immune response in PGRP-LB RNAi
ﬂies that have reduced amidase activity and
are unable to degrade PGN to its nonim-
munogenic form. Transfer of PGN would
provide an indirect mechanism for recogni-
tion of Gram-negative bacteria that may ex-
plain the existence of different PGRP-LC iso-
forms devoted to the detection of monomeric
PGN. Alternatively, one study points to a key
role of nitric oxide as a signaling molecule, in
that ingestion of nitric oxide is sufﬁcient to
trigger an immune response in the absence of
an infection (240, 241).
Finally, a role for hemocytes in the sig-
naling between gut infection and fat body
has been proposed based on the observation
that domino larvae lacking hemocytes failed
to activate a systemic immune response af-
ter Ecc15 infection (154). Cells that express
hemocyte markers are embedded in the ﬁrst
loop of the midgut (B. Lemaitre, unpublished
data). These Drosophila hemocytes might act
similarly to vertebrate M-cells that have an
immune function in the vertebrate digestive
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tract by sampling the contents of the gut
lumen.
Natural bacterial infection: concluding re-
marks. The use of naturally infectious bacte-
ria has revealed the important contribution of
the local immune defense (81, 158, 238). From
this point of view, note that local AMP synthe-
sis in epithelia is a conserved defense mech-
anism within the animal kingdom, whereas
systemic AMP production by the fat body is
probably a more recent adaptation because
it appears to be speciﬁc to holometabolous
insects. Natural infection studies also reveal
common strategies used by bacteria to subvert
the insect immune system such as the pro-
duction of proteases. Why a given bacterial
species can trigger an immune response upon
ingestion is not yet understood. This could be
a simple consequence of bacterial persistence
in a compartment of the gut (leading to a local
increase of a bacterial elicitor) or could reﬂect
speciﬁc properties of the bacteria (release of
PGN). Furthermore, P. entomophila infection
triggers a systemic immune response that has
no overt function against bacteria remaining
in the gut lumen.
Bacterial endosymbionts: Wolbachia. In
contrast to other insect groups, heritable sym-
bionts are uncommon in Drosophila species,
possibly reﬂecting a robust innate immune re-
sponse that eliminates many bacteria (218).
The most frequent endosymbionts are Wol-
bachia, which are intracellular bacteria present
in 30% of all laboratory stocks as well as in
populations in the wild. Wolbachia parasites,
which can only be transmitted vertically from
a female host to her offspring, have evolved
strategies for maximizing their transmission,
such as changing the sex of male ﬂy embryos.
They colonize many different tissues but have
a speciﬁc tropism to reproductive tissues to
ensure their transmission. The recent discov-
ery of PGRP-LE as an intracellular sensor of
Gram-negative bacteria opens the possibili-
ties of an immune defense to intracellular bac-
teria such as Wolbachia (127).
Immunity to Fungi
Extensive ecological studies have been per-
formed on the association between ﬂies and
yeasts. In the wild, ﬂies also play a role in the
dissemination of phytopathogenic fungi. To
date, the ﬂy immune response has been ana-
lyzed in detail in response to two fungi: Beau-
veria bassiana and Candida albicans.
B. bassiana. B. bassiana is an ento-
mopathogenic fungus that infects many
insect species by penetrating their cuticle.
Conidia of B. bassiana germinate on the host
cuticle and differentiate to form an appresso-
rium. An infecting hypha penetrates through
the host cuticle and eventually reaches the
hemocoel. Studies on Metarhizium anisopliae,
a fungus related to B. bassiana, have shown
that entry into the host involves enzymatic
degradation mediated by chitinases, lipases,
and proteases such as PR1 (242). Natural
infection of Drosophila by B. bassiana (initiated
by applying fungal spores on the cuticle) leads
to the expression of the antifungal peptide
genes Drosomycin and Metchnikowin and other
Toll-dependent immune genes through a
selective activation of the Toll pathway (19,
83). Toll-deﬁcient mutants show increased
susceptibility to B. bassiana, which cannot be
rescued by ectopic expression of Drosomycin
(18). Thus, the mechanisms mediating Toll
resistance against B. bassiana have yet to
be established. Finally, melanization is also
believed to play an important role in the
insect host defense mechanism against fungi
(214, 217).
Activation of the Toll pathway by fungi is
mediated by GNBP3 via the sensing ofβ(1,3)-
glucan. Curiously, even GNBP3 mutant ﬂies
upregulate their Toll pathway when they be-
come infected with B. bassiana (131c). In this
condition, the Toll pathway is thought to be
triggered by a fungal protease PR1, which can
lead to cleavage of the host SP Persephone.
In a second step, Persephone activates the SP
cascade acting upstream of Toll. Thus, ﬂies
may sense infection by B. bassiana through
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the production of a fungal virulence factor re-
quired for entry.
C. albicans. C. albicans is an opportunistic
human pathogen. It is a dimorphic fungus,
and it has been suggested that the yeast-to-
hyphae transition plays a pivotal role in its
virulence. Injection of C. albicans into wild-
type ﬂies induces moderate killing, but Toll-
deﬁcient mutants are highly sensitive to this
fungus (243). C. albicans proliferates exten-
sively as pseudohyphae, in a manner similar
to that which occurs in a mammalian host
model. Toll pathway activation by C. albicans
requires GNBP3 (131c). In addition, C. al-
bicans is rapidly phagocytosed by hemocytes,
and experiments in S2 cells have shown that
this process is enhanced by Mcr (178).
Immunity to Parasitoid Wasps
Parasitoids are insects, mostly wasps
(Hymenoptera), that parasitize invertebrates,
mainly insects (244). In contrast to para-
sites, they ultimately kill their hosts by the
ravenous feeding of the preimaginal stages
of the parasitoids. Depending on the species,
females lay one or more eggs into their host.
Upon completion of their development,
adult parasitoids emerge, mate, and disperse
in the environment in search of hosts to
complete their life cycle (Figure 8a). Of
the approximately 50 known species of
Drosophila parasitoids, those belonging to the
Leptopilina, Asobara, and Ganapsis genera have
been studied most intensively. Environmental
studies indicate that there is a high degree
of parasitization of Drosophila populations by
wasps (244). More recently, immunological
aspects of Drosophila-parasitoid relationships
have been analyzed. In Drosophila, cellular en-
capsulation is the most important component
of the immune response against parasitoids
(Figure 8b,c). D. melanogaster and Drosophila
yakuba resistance to infestations of Leptopilina
boulardi are both under the genetic control of
one major gene (245, 245a). For successful
parasitism, parasitoids must circumvent the
host immunity using passive and/or active
mechanisms.
Immune local evasion. Immune local
evasion is achieved when the parasitoid egg
develops in a host site inaccessible to hemo-
cytes or is embedded into host tissues. The
egg can also use a type of molecular disguise
that prevents hosts from recognizing it as
nonself or can be covered by factors causing
a local inactivation of the host defense. An
example of local evasion is observed in Aso-
bara tabida, a braconid wasp that parasitizes
Drosophila larvae in Europe and North Amer-
ica (246, 247). Parasitization by A. tabida
provokes a transient activation of the host
immune system. However, eggs of A. tabida
possess a sticky chorion permitting their
attachment to host tissues. Attachment of the
chorion leads to the complete embedding
of the parasitoid egg within the host tissues,
preventing hemocytes from agglutinating
at the egg surface. Thus A. tabida eggs are
initially recognized by the host, but there
seems to be a race between the immune re-
action and the parasitoid evasion mechanism
to avoid encapsulation (248). The molecular
basis of this evasion mechanism is not
known.
Active immune suppression. The active
suppression of the immune response gener-
ally involves substances that are introduced
into the host by the female wasp at the time
of oviposition. These mechanisms involve fe-
male products such as ovarian protein ven-
oms, virus-like particles, or polydnaviruses.
One of the best examples of active immune
suppression is observed in the interaction be-
tween D. melanogaster and the parasitic wasps
L. boulardi or L. heterotoma. Most strains of
these wasp species are able to bypass the im-
mune response of D. melanogaster. They sup-
press the ﬂy encapsulation response notably
by changing lamellocyte morphology from
a discoidal to a bipolar shape, which pre-
sumably diminishes their ability to adhere
and to form capsules (Figure 8d ) (249–251).
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Figure 8
Drosophila infection by parasitoid wasp. (a) The parasitic wasp Leptopilina boulardi infects Drosophila second
instar larvae (L2) and deposits eggs within the body cavity. (b, c) Encapsulation of the egg is the major
host defense against parasitoid infection. The black capsules are visible through the larval cuticle (b). P,
plasmatocyte. (d ) L. boulardi can suppress the Drosophila encapsulation response by altering lamellocyte
(L) morphology from a discoidal to a bipolar shape. L, normal lamellocyte; mod. L, bipolar-shaped
lamellocyte. Courtesy of Aurore Dubuffet (a–c) and Corinne Labrosse (d ), University of Tours, France.
Virus-like particles (VLPs) produced in the
female long gland and the reservoir are in-
jected together with the eggs and have been
associated with immune suppression. P4, one
of the proteins present in the long glands, was
recently isolated from L. boulardi and demon-
strated to be a Rho-GAP domain-containing
protein (252, 253). Rho-GAP proteins are act-
ing as inhibitors of Rho GTPases that are
involved in the actin cytoskeleton reorgani-
zation. The observations that (a) the ability
to detect the P4 protein in female parasitoids
correlates with their virulence and (b) its injec-
tion in the host alters lamellocyte morphology
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establish this protein as a main immune-
suppressive factor of L. boulardi. Similarly,
a 40-kDa protein with immune-suppressive
properties was identiﬁed at the surface of
VLPs in L. heterotoma (254, 255).
Another strategy of immune suppression is
observed with Asobara citri, a parasitoid devoid
of VLPs. A. citri appears to suppress the host
immune system by directly affecting the
hematopoietic organ and, consequently, the
number of circulating hemocytes (256). In-
deed, the size of the anterior lymph glands is
strongly reduced in larvae of D. melanogaster
parasitized by A. citri. The molecular mecha-
nism underlying lymph gland necrosis caused
by A. citri is not known.
ANTIVIRAL IMMUNITY
Viruses are important natural pathogens of
D. melanogaster: 40% of all ﬂies are infected
with horizontally transmitted viruses, and ver-
tical transmission of viruses is also common
in this species (218, 257). More than 25 dis-
tinct Drosophila viruses have been identiﬁed,
all RNA viruses (218, 257a). Although there
is an extensive literature on the association be-
tween viruses and Drosophila, only the immune
response to viruses, especially to the Sigma
and Drosophila C virus (DCV), has been in-
vestigated. Drosophila host reactions to viruses
are clearly distinct from those involved in the
defense against microbes or parasites. To date,
RNAi is the sole immune effector mecha-
nism directed against viruses identiﬁed in this
insect.
Sigma Virus
The Sigma virus, a rhabdovirus related
to vesicular stomatitis virus of horses, is
widespread in natural populations of D.
melanogaster and is normally transmitted ver-
tically from ﬂy to ﬂy via the egg. Viruses can,
however, also be artiﬁcially transmitted by in-
jection of tissue extracts derived from an in-
fected ﬂy. Flies carrying the Sigma virus ap-
pear normal, but die after benign exposure
DCV: Drosophila C
virus
to carbon dioxide. Natural populations of D.
melanogaster are often polymorphic for non-
permissive alleles of genes that are known col-
lectively as ref (refractory) and that prevent
virus replication in cells. Ref(2)P, the best-
characterized among the ﬁve ref genes iden-
tiﬁed, encodes a PEST domain protein that
is highly variable in sequence between al-
leles of natural populations (258, 259). A null
mutation in ref(2)P is permissive to the Sigma
virus, but causes male sterility, indicating that
this gene has an endogenous function in ﬂies.
The molecular mechanism by which the re-
strictive allele of ref(2)P blocks Sigma repli-
cation is not known, although direct inter-
action has been suggested between ref(2)P
protein encoded by restrictive alleles and the
viral RNA polymerase (260). Because the
Sigma virus can mutate to overcome the ﬂy
resistance to infection resulting from a re-
fractory phenotype, there is probably an arms
race between the viral genome and the host
genome. Collectively, these studies indicate
that a high polymorphism of ref genes plays
an important role at the level of populations
to limit Sigma infections.
Drosophila C Virus (DCV)
DCV is a nonenveloped single-stranded RNA
virus similar to vertebrate picornaviruses.
Flies isolated in different parts of the world
display varying susceptibility to this virus.
It is horizontally transmitted through con-
tact or ingestion, but to date only injections
have been used to ensure reproducible in-
fection and lethality under laboratory con-
ditions. Genome screening with S2 cells
has identiﬁed a large number of Drosophila
genes required for virus entry and repli-
cation, notably genes encoding components
of the clathrin-mediated endocytic pathway
(261–262a).
Proteomic and microarray analyses were
performed on DCV-injected ﬂies to analyze
the global immune response to DCV. One
molecule, pherokine-2, was found to be in-
duced at the posttranscriptional level in the
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hemolymph of DCV-infected ﬂies (263). The
high expression of pherokine-2 during meta-
morphosis pointed to a possible role of this
gene in tissue remodeling. DCV infection
triggers a transcriptional response in ﬂies that
signiﬁcantly differs from that triggered by
bacteria or fungi (91). Some of the DCV-
speciﬁc responsive genes are regulated by the
JAK-STAT pathway, a cascade that plays an
important role in the antiviral response in
mammals. One of the DCV-responsive genes,
vir1, is induced 24 h after viral infection in
the ventral epidermis, but not in the fat body,
in a JAK-STAT-dependent manner. A role
for the JAK-STAT pathway in antiviral de-
fense is also supported by the observation that
ﬂies deﬁcient in the JAK kinase Hopscotch
exhibit increased susceptibility to DCV and
contain a higher viral load. These data sug-
gest that ﬂies produce antiviral molecules in a
JAK-STAT-dependent manner, although, to
date, none of the identiﬁed DCV-regulated
genes has been shown to manifest direct an-
tiviral activity. DCV infection does not in-
duce expression of the JAK-STAT-dependent
stress-induced gene Turandots, at least in the
ﬁrst 3 days of infection before tissue dam-
age becomes apparent. Some components
of the Toll pathway (Toll and Dif, but not
Pelle and Tube) have also been implicated
in the resistance against Drosophila X virus
(264).
These studies support the existence of an
antiviral signaling response in Drosophila and
raise many new questions (265). For one, the
mechanisms by which Drosophila recognizes
viral infection have not yet been worked out.
In particular, it will be important to determine
whether the transcriptional response to viral
infection is triggered by intracellular pattern
recognition receptors and/or can depend on
signals from virus-induced tissue damage. A
second point of importance will be the iden-
tiﬁcation of antiviral molecules in Drosophila.
Finally, it seems appropriate to study the im-
mune response after natural viral infection be-
cause the route of entry may inﬂuence the host
response: Only few genes were induced in mi-
croarray studies after oral ingestion of DCV
(266), in contrast to the robust response ob-
served after DCV injection (91).
RNAi as an Antiviral Immune
Response Against RNA Viruses
RNAi provides an antiviral defense in plants
and animals that is able to seek out and destroy
viral RNA. RNAi is initiated by the recogni-
tion of dsRNA through Dicer 2, which cleaves
newly synthesized viral dsRNA, generating
siRNAs (small interfering RNA) that “guide”
the RISC complex to speciﬁcally recognize
and degrade viral RNA. Recent reports have
underlined the importance of this mechanism
in the Drosophila antiviral response. Mutations
in argonaute-2 or Dicer 2, which affect the
RNAi pathway, increased the susceptibility of
ﬂies to a large number of RNA viruses includ-
ing DCV, Flock House virus (FHV), Sinbis,
and Drosophila X virus (267–269a). Successful
infection and killing of Drosophila by the in-
sect nodavirus or FHV are strictly dependent
on the viral protein B2, a potent inhibitor of
dsRNA processing by Dicer. A signiﬁcant role
of RNAi in the Drosophila antiviral defense
is further supported by the observation that
three genes involved in the RNAi response
against viruses, but not their housekeeping
miRNA paralogs, are in the top 3% of fast-
evolving genes in the D. melanogaster genome,
which is often a signature of a host-pathogen
arms race (270).
Although still preliminary, these studies
suggest the existence of two types of responses
to virus infection: degradation of viral RNA
by RNAi and cytokine activation through the
JAK-STAT pathway of a number of genes,
which may counter viral infection.
PERSPECTIVES
In recent years considerable progress has
been made in our understanding of the im-
mune response of Drosophila, now one of the
best-characterized host defense systems of
metazoans. The success of this model largely
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relies on the possibility of applying genetic
and genomic approaches to this organism.
This situation will probably prevail in the
future because Drosophila genetics remain
among the most powerful and cost-effective
approaches when compared to other models.
Indeed, injection of dsRNA, which opened
the route to functional studies in other insects,
has its limitations. In particular, the injection
procedure can perturb the response under
investigation, and this may be critical when
analyzing subtle aspects of the immune sys-
tem. Ultimately, classical genetics, including
the generation of animals carrying multiple
mutations in deﬁned genetic backgrounds, are
feasible in Drosophila, but not in other insects.
Such methodology thus remains mandatory
to the generation and validation of solid
data.
An attractive feature of the ﬂy immune re-
sponse is the existence of multiple defense
“modules” that can be deployed in a coor-
dinated response against distinct pathogens.
The prominent immune reactions, such as
AMP production, iron sequestration, phago-
cytosis, and ROS production, appear to be
shared with vertebrates, whereas others, such
as melanization and encapsulation by lamel-
locytes, are restricted to invertebrates. An-
alyzing the precise molecular mechanisms
underlying each of these reactions remains
an essential task for our full understanding of
the ﬂy immune response. In parallel, investi-
gations concentrating on the global immune
response to one speciﬁc pathogen are comple-
mentary since they provide a more integrated
view of the immune system demonstrating
how these defense “modules” interact. The
hope is that these combined approaches will
reveal more coherence among the many as-
pects of ﬂy defense mechanisms, which still
appear dissociated. In the future, addressing
the interactions between immunity and other
physiological functions (e.g., metabolism, or
adaptation to environmental stress) will as-
sist in discerning the relationships of the
immune system with other aspects of ﬂy
life.
The remarkable similarities between
Drosophila host defense and essential facets
of vertebrate innate immunity clearly point
to a common ancestry in evolution. This
is particularly striking with regard to the
intracellular signaling pathways activated
upon infections. A precise understanding of
the evolution of innate immune responses in
metazoans will obviously require the study of
these defense reactions in other invertebrate
species and should allow discrimination
between recent acquisitions and conserved
mechanisms. From this point of view, the re-
cent genomic sequencing of several Drosophila
species as well as that of other insects has
also launched Drosophila as a model for
studying microevolution between closely
related species. Several interesting studies,
not discussed in this review, are investigating
the genetic basis of immune competence
variations among Drosophila populations
and the diversity of immune genes among
insect species. Major differences can be
observed between closely related species.
To illustrate this, some Drosophila species,
such as D. pseudoobscura, lack the capacity to
encapsulate parasitoids due to the absence
of lamellocytes (183). It has been proposed
that this natural case of constitutive immune
deﬁciency could represent an unexpected and
risky strategy: The absence of a particular
immune “module” may be beneﬁcial as it
economizes valuable resources allocated to
this mechanism. Thus, studies comparing
immune systems of related species or even
populations of D. melanogaster may reveal
differences in host defense strategies. This
comparison will probably underline the
importance of ecology in shaping an im-
mune system and should lead to a better
understanding of adaptation. As Jiggins &
Kim point out (271), there is no reported
specialist fungal or bacterial pathogen for
D. melanogaster. This may be related to its
ecology as Drosophila have short life spans and
live on ephemeral food patches. It is possible
that most D. melanogaster pathogens are
generalists infecting many species, which in
www.annualreviews.org • Host Defense of Drosophila melanogaster 727
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turn restricts the opportunity for coevolution.
This mode of life has strong implications
for determining the nature of the immune
system. Future studies may well reveal
interesting links between Drosophila immune
defense and the ecology of this insect.
ACKNOWLEDGMENTS
The authors apologize for their inability to quote many additional contributions due to space
limitations. We thank Charles Hetru for graphics conception; Christoph Scherfer, Marie
Meister, Anna Zaidman, and Maryle`ne Poirie´ for critical reading; and Ulrich Theopold,
Corinne Labrosse, and Aurore Dubuffet for providing images.
LITERATURE CITED
1. Tzou P, De Gregorio E, Lemaitre B. 2002. How Drosophila combats microbial infection:
a model to study innate immunity and host-pathogen interactions. Curr. Opin. Microbiol.
5:102–10
2. Hultmark D. 2003. Drosophila immunity: paths and patterns. Curr. Opin. Immunol. 15:12–
19
3. Hoffmann JA. 2003. The immune response of Drosophila. Nature 426:33–38
4. Brennan CA, Anderson KV. 2004. Drosophila: the genetics of innate immune recognition
and response. Annu. Rev. Immunol. 22:457–83
5. Lemaitre B. 2004. The road to Toll. Nat. Rev. Immunol. 4:521–27
6. Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, et al. 2000.
Comparative genomics of the eukaryotes. Science 287:2204–15
7. Boman HG, Nilsson I, Rasmuson B. 1972. Inducible antibacterial defense system in
Drosophila. Nature 237:232–35
8. Imler JL, Bulet P. 2005. Antimicrobial peptides in Drosophila: structures, activities and
gene regulation. Chem. Immunol. Allergy 86:1–21
9. Wicker C, Reichhart JM, Hoffmann D, Hultmark D, Samakovlis C, Hoffmann JA.
1990. Insect immunity: characterization of a Drosophila cDNA encoding a novel member
of the diptericin family of immune peptides. J. Biol. Chem. 265:22493–98
10. Asling B, Dushay MS, Hultmark D. 1995. Identiﬁcation of early genes in the Drosophila
immune response by PCR-based differential display: the Attacin A gene and the evolu-
tion of attacin-like proteins. Insect. Biochem. Mol. Biol. 25:511–18
11. Bulet P, Dimarcq JL, Hetru C, Lagueux M, Charlet M, et al. 1993. A novel inducible
antibacterial peptide of Drosophila carries an O-glycosylated substitution. J. Biol. Chem.
268:14893–97
12. Dimarcq JL, Hoffmann D, Meister M, Bulet P, Lanot R, et al. 1994. Characterization
and transcriptional proﬁles of a Drosophila gene encoding an insect defensin. A study in
insect immunity. Eur. J. Biochem. 221:201–9
13. Fehlbaum P, Bulet P, Michaut L, Lagueux M, Broeckaert W, et al. 1994. Insect immu-
nity: Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with
sequence homology to plant antifungal peptides. J. Biol. Chem. 269:33159–63
14. Levashina E, Ohresser S, Bulet P, Reichhart J, Hetru C, Hoffmann J. 1995. Metch-
nikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibac-
terial and antifungal properties. Eur. J. Biochem. 233:694–700
15. Kylsten P, Samakovlis C, Hultmark D. 1990. The cecropin locus in Drosophila: a compact
gene cluster involved in the response to infection. EMBO J. 9:217–24
728 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
16. Ekengren S, Hultmark D. 1999. Drosophila cecropin as an antifungal agent. Insect.
Biochem. Mol. Biol. 29:965–72
17. Uttenweiler-Joseph S, Moniatte M, Lagueux M, Van Dorsselaer A, Hoffmann JA,
Bulet P. 1998. Differential display of peptides induced during the immune response of
Drosophila: a matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry
study. Proc. Natl. Acad. Sci. USA 95:11342–47
18. Tzou P, Reichhart JM, Lemaitre B. 2002. Constitutive expression of a single antimicro-
bial peptide can restore wild-type resistance to infection in immuno-deﬁcient Drosophila
mutants. Proc. Natl. Acad. Sci. USA 99:2152–57
19. De Gregorio E, Spellman PT, Rubin GM, Lemaitre B. 2001. Genome-wide analysis of
the Drosophila immune response by using oligonucleotide microarrays. Proc. Natl. Acad.
Sci. USA 98:12590–95
20. Irving P, Troxler L, Heuer TS, Belvin M, Kopczynski C, et al. 2001. A genome-wide
analysis of immune responses in Drosophila. Proc. Natl. Acad. Sci. USA 98:15119–24
21. Boutros M, Agaisse H, Perrimon N. 2002. Sequential activation of signaling pathways
during innate immune responses in Drosophila. Dev. Cell 3:711–22
22. Vierstraete E, Cerstiaens A, Baggerman G, Van den Bergh G, De Loof A, Schoofs
L. 2003. Proteomics in Drosophila melanogaster: ﬁrst 2D database of larval hemolymph
proteins. Biochem. Biophys. Res. Commun. 304:831–38
23. Vierstraete E, Verleyen P, Baggerman G, D’Hertog W, Van den Bergh G, et al. 2004. A
proteomic approach for the analysis of instantly released wound and immune proteins
in Drosophila melanogaster hemolymph. Proc. Natl. Acad. Sci. USA 101:470–75
24. Levy F, Bulet P, Ehret-Sabatier L. 2004. Proteomic analysis of the systemic immune
response of Drosophila. Mol. Cell. Proteomics 3:156–66
25. Levy F, Rabel D, Charlet M, Bulet P, Hoffmann JA, Ehret-Sabatier L. 2004. Peptidomic
and proteomic analyses of the systemic immune response of Drosophila. Biochimie 86:607–
16
26. Ekengren S, Tryselius Y, Dushay MS, Liu G, Steiner H, Hultmark D. 2001. A humoral
stress response in Drosophila. Curr. Biol. 11:714–18
27. Ekengren S, Hultmark D. 2001. A family of Turandot-related genes in the humoral
stress response of Drosophila. Biochem. Biophys. Res. Commun. 284:998–1003
28. Yoshiga T, Georgieva T, Dunkov BC, Harizanova N, Ralchev K, Law JH. 1999.
Drosophila melanogaster transferrin. Cloning, deduced protein sequence, expression dur-
ing the life cycle, gene localization and up-regulation on bacterial infection. Eur. J.
Biochem. 260:414–20
29. Kadalayil L, Petersen UM, Engstrom Y. 1997. Adjacent GATA and κB-like motifs reg-
ulate the expression of a Drosophila immune gene. Nucleic Acids Res. 25:1233–39
30. Petersen UM, Kadalayil L, Rehorn KP, Hoshizaki DK, Reuter R, Engstrom Y. 1999.
Serpent regulates Drosophila immunity genes in the larval fat body through an essential
GATA motif. EMBO J. 18:4013–22
31. Tingvall TO, Roos E, Engstrom Y. 2001. The GATA factor Serpent is required for the
onset of the humoral immune response in Drosophila embryos. Proc. Natl. Acad. Sci. USA
98:3884–88
32. Uvell H, Engstrom Y. 2003. Functional characterization of a novel promoter element
required for an innate immune response in Drosophila. Mol. Cell. Biol. 23:8272–81
33. Senger K, Armstrong GW, Rowell WJ, Kwan JM, Markstein M, Levine M. 2004.
Immunity regulatory DNAs share common organizational features in Drosophila. Mol.
Cell 13:19–32
www.annualreviews.org • Host Defense of Drosophila melanogaster 729
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
34. Kappler C, Meister M, Lagueux M, Gateff E, Hoffmann JA, Reichhart JM. 1993. In-
sect immunity. Two 17bp repeats nesting a κB-related sequence confer inducibility to
the diptericin gene and bind a polypeptide in bacteria-challenged Drosophila. EMBO J.
12:1561–68
35. Engstrom Y, Kadalayil L, Sun SC, Samakovlis C, Hultmark D, Faye I. 1993. κB-like
motifs regulate the induction of immune genes in Drosophila. J. Mol. Biol. 232:327–33
36. Meister M, Braun A, Kappler C, Reichhart JM, Hoffmann JA. 1994. Insect immunity.
A transgenic analysis in Drosophila deﬁnes several functional domains in the diptericin
promoter. EMBO J. 13:5958–66
37. Ip YT, Reach M, Engstrom Y, Kadalayil L, Cai H, et al. 1993. Dif, a dorsal-related gene
that mediates an immune response in Drosophila. Cell 75:753–63
38. Reichhart JM, Georgel P, Meister M, Lemaitre B, Kappler C, Hoffmann JA. 1993.
Expression and nuclear translocation of the rel/NF-kB-related morphogen dorsal during
the immune response of Drosophila. C.R. Acad. Sci. III 316:1218–24
39. Dushay MS, Asling B, Hultmark D. 1996. Origins of immunity: Relish, a compound Rel-
like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343–47
39a. Steward R. 1987. Dorsal, an embryonic polarity gene in Drosophila, is homologous to
the vertebrate proto-oncogene c-rel. Science 238:692–94
40. Petersen UM, Bjorklund G, Ip YT, Engstrom Y. 1995. The dorsal related immunity
factor, Dif, is a sequence speciﬁc trans-activator of Drosophila cecropin gene expression.
EMBO J. 14:3146–58
41. Gross I, Georgel P, Kappler C, Reichhart JM, Hoffmann JA. 1996. Drosophila immunity:
a comparative analysis of the Rel proteins dorsal and Dif in the induction of the genes
encoding diptericin and cecropin. Nucleic Acids Res. 24:1238–45
42. Belvin MP, Anderson KV. 1996. A conserved signaling pathway: the Drosophila Toll-
dorsal pathway. Annu. Rev. Cell Dev. Biol. 12:393–416
43. Tauszig-Delamasure S, Bilak H, Capovilla M, Hoffmann JA, Imler JL. 2002. Drosophila
MyD88 is required for the response to fungal and Gram-positive bacterial infections.
Nat. Immunol. 3:91–97
44. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. 1996. The dorsoventral
regulatory gene cassette Spa¨tzle/Toll/cactus controls the potent antifungal response in
Drosophila adults. Cell 86:973–83
44a. Rutschmann S, Kilinc A, Ferrandon D. 2002. Cutting edge: The Toll pathway is required
for resistance to gram-positive bacterial infections in Drosophila. J. Immunol. 168:1542–
46
45. Meng X, Khanuja BS, Ip YT. 1999. Toll receptor-mediated Drosophila immune response
requires Dif, an NF-κB factor. Genes Dev. 13:792–97
46. Manfruelli P, Reichhart JM, Steward R, Hoffmann JA, Lemaitre B. 1999. A mosaic
analysis in Drosophila fat body cells of the control of antimicrobial peptide genes by the
Rel proteins Dorsal and DIF. EMBO J. 18:3380–91
47. Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, Ferrandon D. 2000.
The Rel protein DIF mediates the antifungal but not the antibacterial host defense in
Drosophila. Immunity 12:569–80
48. Bettencourt R, Asha H, Dearolf C, Ip YT. 2004. Hemolymph-dependent and
-independent responses in Drosophila immune tissue. J. Cell. Biochem. 92:849–63
49. De Gregorio E, Spellman PT, Tzou P, Rubin GM, Lemaitre B. 2002. The Toll and
Imd pathways are the major regulators of the immune response in Drosophila. EMBO J.
21:2568–79
730 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
50. Nicolas E, Reichhart JM, Hoffmann JA, Lemaitre B. 1998. In vivo regulation of the IκB
homologue cactus during the immune response of Drosophila. J. Biol. Chem. 273:10463–
69
51. Weber AN, Tauszig-Delamasure S, Hoffmann JA, Lelievre E, Gascan H, et al. 2003.
Binding of the Drosophila cytokine Spa¨tzle to Toll is direct and establishes signaling. Nat.
Immunol. 4:794–800
52. Hu X, Yagi Y, Tanji T, Zhou S, Ip YT. 2004. Multimerization and interaction of Toll
and Spa¨tzle in Drosophila. Proc. Natl. Acad. Sci. USA 101:9369–74
53. Tauszig S, Jouanguy E, Hoffmann JA, Imler JL. 2000. Toll-related receptors and the
control of antimicrobial peptide expression in Drosophila. Proc. Natl. Acad. Sci. USA
97:10520–25
54. Ooi JY, Yagi Y, Hu X, Ip YT. 2002. The Drosophila Toll-9 activates a constitutive an-
timicrobial defense. EMBO Rep. 3:82–87
55. Lemaitre B, Kromer-Metzger E, Michaut L, Nicolas E, Meister M, et al. 1995. A re-
cessive mutation, immune deﬁciency (imd), deﬁnes two distinct control pathways in the
Drosophila host defense. Proc. Natl. Acad. Sci. USA 92:9365–469
56. Corbo JC, Levine M. 1996. Characterization of an immunodeﬁciency mutant in
Drosophila. Mech. Dev. 55:211–20
57. Levashina E, Ohresser S, Lemaitre B, Imler J. 1998. Two distinct pathways can control
expression of the Drosophila antimicrobial peptide metchnikowin. J. Mol. Biol. 278:515–
27
58. Georgel P, Naitza S, Kappler C, Ferrandon D, Zachary D, et al. 2001. Drosophila immune
deﬁciency (IMD) is a death domain protein that activates antibacterial defense and can
promote apoptosis. Dev. Cell 1:503–14
59. Gottar M, Gobert V, Michel T, Belvin M, Duyk G, et al. 2002. The Drosophila immune
response against Gram-negative bacteria is mediated by a peptidoglycan recognition
protein. Nature 416:640–44
60. Choe KM, Werner T, Stoven S, Hultmark D, Anderson KV. 2002. Requirement for a
peptidoglycan recognition protein (PGRP) in Relish activation and antibacterial immune
responses in Drosophila. Science 296:359–62
61. Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA. 2002. Functional
genomic analysis of phagocytosis and identiﬁcation of a Drosophila receptor for E. coli.
Nature 416:644–48
62. Vidal S, Khush RS, Leulier F, Tzou P, Nakamura M, Lemaitre B. 2001. Mutations in
the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control
of rel/NF-κB-dependent innate immune responses. Genes Dev. 15:1900–12
63. Silverman N, Zhou R, Erlich RL, Hunter M, Bernstein E, et al. 2003. Immune activation
of NF-κB and JNK requires Drosophila TAK1. J. Biol. Chem. 278:48928–34
64. Gesellchen V, Kuttenkeuler D, Steckel M, Pelte N, Boutros M. 2005. An RNA interfer-
ence screen identiﬁes Inhibitor of Apoptosis Protein 2 as a regulator of innate immune
signaling in Drosophila. EMBO Rep. 6:979–84
65. Kleino A, Valanne S, Ulvila J, Kallio J, Myllymaki H, et al. 2005. Inhibitor of apoptosis
2 and TAK1-binding protein are components of the Drosophila Imd pathway. EMBO J.
24:3423–34
66. Zhuang ZH, Sun L, Kong L, Hu JH, Yu MC, et al. 2006. Drosophila TAB2 is required
for the immune activation of JNK and NF-κB. Cell. Signal. 18:964–70
67. Leulier F, Lhocine N, Lemaitre B, Meier P. 2006. The Drosophila IAP DIAP2 functions
in innate immunity and is essential to resist gram-negative bacterial infection. Mol. Cell.
Biol. 26:7821–31
www.annualreviews.org • Host Defense of Drosophila melanogaster 731
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
68. Silverman N, Zhou R, Stoven S, Pandey N, Hultmark D, Maniatis T. 2000. A Drosophila
IκB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev.
14:2461–71
69. Rutschmann S, Jung AC, Zhou R, Silverman N, Hoffmann JA, Ferrandon D. 2000.
Role of Drosophila IKKγ in a Toll-independent antibacterial immune response. Nature
Immunol. 1:342–47
70. Lu Y, Wu LP, Anderson KV. 2001. The antibacterial arm of the Drosophila innate
immune response requires an IκB kinase. Genes Dev. 15:104–10
71. Leulier F, Vidal S, Saigo K, Ueda R, Lemaitre B. 2002. Inducible expression of double-
stranded RNA reveals a role for dFADD in the regulation of the antibacterial response
in Drosophila adults. Curr. Biol. 12:996–1000
72. Naitza S, Rosse C, Kappler C, Georgel P, Belvin M, et al. 2002. The Drosophila immune
defense against gram-negative infection requires the death protein dFADD. Immunity
17:575–81
73. Leulier F, Rodriguez A, Khush RS, Abrams JM, Lemaitre B. 2000. The Drosophila caspase
Dredd is required to resist gram-negative bacterial infection. EMBO Rep. 1:353–58
74. Hedengren M, Asling B, Dushay MS, Ando I, Ekengren S, et al. 1999. Relish, a central
factor in the control of humoral but not cellular immunity in Drosophila. Mol. Cell 4:827–
37
75. Khush RS, Cornwell WD, Uram JN, Lemaitre B. 2002. A ubiquitin-proteasome pathway
represses the Drosophila immune deﬁciency signaling cascade. Curr. Biol. 12:1728–37
76. Cha GH, Cho KS, Lee JH, Kim M, Kim E, et al. 2003. Discrete functions of TRAF1
and TRAF2 in Drosophila melanogaster mediated by c-Jun N-terminal kinase and NF-
κB-dependent signaling pathways. Mol. Cell. Biol. 23:7982–91
77. Foley E, O’Farrell PH. 2004. Functional dissection of an innate immune response by a
genome-wide RNAi screen. PLoS Biol. 2:e203
78. Zhou R, Silverman N, Hong M, Liao DS, Chung Y, et al. 2005. The role of ubiquiti-
nation in Drosophila innate immunity. J. Biol. Chem. 280:34048–55
79. Yagi Y, Ip YT. 2005. Helicase89B is a Mot1p/BTAF1 homologue that mediates an
antimicrobial response in Drosophila. EMBO Rep. 6:1088–94
80. Tsuda M, Langmann C, Harden N, Aigaki T. 2005. The RING-ﬁnger scaffold protein
plenty of SH3s targets TAK1 to control immunity signaling in Drosophila. EMBO Rep.
6:1082–87
80a. Kim M, Lee JH, Lee SY, Kim E, Chung J. 2006. Caspar, a suppressor of antibacterial
immunity in Drosophila. Proc. Natl. Acad. Sci. USA 103:16358–63
81. Bangham J, Jiggins F, Lemaitre B. 2006. Insect immunity: the postgenomic era. Immu-
nity 25:1–5
82. Tzou P, Ohresser S, Ferrandon D, Capovilla M, Reichhart JM, et al. 2000. Tissue-
speciﬁc inducible expression of antimicrobial peptide genes in Drosophila surface epithe-
lia. Immunity 13:737–48
83. Lemaitre B, Reichhart J, Hoffmann J. 1997. Drosophila host defense: differential induc-
tion of antimicrobial peptide genes after infection by various classes of microorganisms.
Proc. Natl. Acad. Sci. USA 94:14614–19
84. Meister M, Richards G. 1996. Ecdysone and insect immunity: the maturation of the
inducibility of the diptericin gene in Drosophila larvae. Insect. Biochem. Mol. Biol. 26:155–
60
85. Ligoxygakis P, Bulet P, Reichhart JM. 2002. Critical evaluation of the role of the Toll-
like receptor 18-Wheeler in the host defense of Drosophila. EMBO Rep. 3:666–73
732 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
86. Agaisse H, Perrimon N. 2004. The roles of JAK/STAT signaling in Drosophila immune
responses. Immunol. Rev. 198:72–82
87. Barillas-Mury C, Han YS, Seeley D, Kafatos FC. 1999. Anopheles gambiae Ag-STAT, a
new insect member of the STAT family, is activated in response to bacterial infection.
EMBO J. 18:959–67
88. Lagueux M, Perrodou E, Levashina EA, Capovilla M, Hoffmann JA. 2000. Constitutive
expression of a complement-like protein in Toll and JAK gain-of-function mutants of
Drosophila. Proc. Natl. Acad. Sci. USA 97:11427–32
89. Agaisse H, Petersen UM, Boutros M, Mathey-Prevot B, Perrimon N. 2003. Signaling
role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury. Dev.
Cell 5:441–50
90. Brun S, Vidal S, Spellman P, Takahashi K, Tricoire H, Lemaitre B. 2006. The MAPKKK
Mekk1 regulates the expression of Turandot stress genes in response to septic injury in
Drosophila. Genes Cells 11:397–407
91. Dostert C, Jouanguy E, Irving P, Troxler L, Galiana-Arnoux D, et al. 2005. The Jak-
STAT signaling pathway is required but not sufﬁcient for the antiviral response of
Drosophila. Nat. Immunol. 6:946–53
92. Ra¨met M, Lanot R, Zachary D, Manfruelli P. 2001. JNK signaling pathway is required
for efﬁcient wound healing in Drosophila. Dev. Biol. 241:145–56
93. Galko MJ, Krasnow MA. 2004. Cellular and genetic analysis of wound healing in
Drosophila larvae. PLoS Biol. 2:e239
94. Park JM, Brady H, Ruocco MG, Sun H, Williams D, et al. 2004. Targeting of TAK1 by
the NF-κB protein Relish regulates the JNK-mediated immune response in Drosophila.
Genes Dev. 18:584–94
95. Kim T, Yoon J, Cho H, Lee WB, Kim J, et al. 2005. Downregulation of lipopolysaccha-
ride response in Drosophila by negative crosstalk between the AP1 and NF-κB signaling
modules. Nat. Immunol. 6:211–18
96. Kallio J, Leinonen A, Ulvila J, Valanne S, Ezekowitz RA, Ramet M. 2005. Functional
analysis of immune response genes in Drosophila identiﬁes JNK pathway as a regulator
of antimicrobial peptide gene expression in S2 cells. Microbes Infect. 7:811–19
97. Delaney JR, Stoven S, Uvell H, Anderson KV, Engstrom Y, Mlodzik M. 2006. Coopera-
tive control of Drosophila immune responses by the JNK and NF-κB signaling pathways.
EMBO J. 25:3068–77
98. Asai T, Tena G, Plotnikova J, Willmann M, Chiu W, et al. 2002. MAP kinase signaling
cascade in Arabidopsis innate immunity. Nature 415:977–83
99. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, et al. 2002. A conserved
p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297:977–83
100. Craig CR, Fink JL, Yagi Y, Ip YT, Cagan RL. 2004. A Drosophila p38 orthologue is
required for environmental stress responses. EMBO Rep. 5:1058–63
101. Zhuang ZH, Zhou Y, Yu MC, Silverman N, Ge BX. 2005. Regulation of Drosophila p38
activation by speciﬁc MAP2 kinase and MAP3 kinase in response to different stimuli.
Cell. Signal. 18:441–48
102. Igaki T, Kanda H, Yamamoto-Goto Y, Kanuka H, Kuranaga E, et al. 2002. Eiger, a TNF
superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 21:3009–18
103. Moreno E, Yan M, Basler K. 2002. Evolution of TNF signaling mechanisms: JNK-
dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily.
Curr. Biol. 12:1263–68
104. Yoshida H, Kinoshita K, Ashida M. 1996. Puriﬁcation of a peptidoglycan recognition
protein from hemolymph of the silkworm, Bombyx mori. J. Biol. Chem. 271:13854–60
www.annualreviews.org • Host Defense of Drosophila melanogaster 733
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
105. Lee WJ, Lee JD, Kravchenko VV, Ulevitch RJ, Brey PT. 1996. Puriﬁcation and molec-
ular cloning of an inducible gram-negative bacteria-binding protein from the silkworm,
Bombyx mori. Proc. Natl. Acad. Sci. USA 93:7888–93
106. Kang D, Liu G, Lundstrom A, Gelius E, Steiner H. 1998. A peptidoglycan recognition
protein in innate immunity conserved from insects to humans. Proc. Natl. Acad. Sci. USA
95:10078–82
107. Mengin-Lecreulx D, Lemaitre B. 2005. Structure and metabolism of peptidoglycan and
molecular requirements allowing its detection by the Drosophila innate immune system.
J. Endotoxin Res. 11:105–11
108. Leulier F, Parquet C, Pili-Floury S, Ryu JH, Caroff M, et al. 2003. The Drosophila im-
mune system detects bacteria through speciﬁc peptidoglycan recognition. Nat. Immunol.
4:478–84
109. Kaneko T, Goldman WE, Mellroth P, Steiner H, Fukase K, et al. 2004. Monomeric and
polymeric gram-negative peptidoglycan but not puriﬁed LPS stimulate the Drosophila
IMD pathway. Immunity 20:637–49
110. Stenbak CR, Ryu JH, Leulier F, Pili-Floury S, Parquet C, et al. 2004. Peptidoglycan
molecular requirements allowing detection by the Drosophila immune deﬁciency path-
way. J. Immunol. 173:7339–48
111. Filipe SR, Tomasz A, Ligoxygakis P. 2005. Requirements of peptidoglycan structure
that allow detection by the Drosophila Toll pathway. EMBO Rep. 6:327–33
112. Werner T, Liu G, Kang D, Ekengren S, Steiner H, Hultmark D. 2000. A family of
peptidoglycan recognition proteins in the fruit ﬂy Drosophila melanogaster. Proc. Natl.
Acad. Sci. USA 97:13772–77
113. Steiner H. 2004. Peptidoglycan recognition proteins: on and off switches for innate
immunity. Immunol. Rev. 198:83–96
114. Royet J, Reichhart JM, Hoffmann JA. 2005. Sensing and signaling during infection in
Drosophila. Curr. Opin. Immunol. 17:11–17
115. Mellroth P, Karlsson J, Steiner H. 2003. A scavenger function for a Drosophila peptido-
glycan recognition protein. J. Biol. Chem. 278:7059–64
116. Zaidman-Remy A, Herve M, Poidevin M, Pili-Floury S, Kim MS, et al. 2006. The
Drosophila amidase PGRP-LB modulates the immune response to bacterial infection.
Immunity 24:463–73
116a. Mellroth P, Steiner H. 2006. PGRP-SB1: an N-acetylmuramoyl l-alanine amidase with
antibacterial activity. Biochem. Biophys. Res. Commun. 350:994–99
117. Bischoff V, Vignal C, Duvic B, Boneca IG, Hoffmann JA, Royet J. 2006. Downregulation
of the Drosophila immune response by peptidoglycan-recognition proteins SC1 and SC2.
PLoS Pathog. 2:e14
118. Kim MS, Byun M, Oh BH. 2003. Crystal structure of peptidoglycan recognition protein
LB from Drosophila melanogaster. Nat. Immunol. 4:787–93
119. Chang CI, Pili-Floury S, Herve M, Parquet C, Chelliah Y, et al. 2004. A Drosophila
pattern recognition receptor contains a peptidoglycan docking groove and unusual L,D-
carboxypeptidase activity. PLoS Biol. 2:e277
120. Lim JH, Kim MS, Kim HE, Yano T, Oshima Y, et al. 2006. Structural basis for preferen-
tial recognition of diaminopimelic acid-type peptidoglycan by a subset of peptidoglycan
recognition proteins. J. Biol. Chem. 281:8286–95
121. Chang CI, Ihara K, Chelliah Y, Mengin-Lecreulx D, Wakatsuki S, Deisenhofer J.
2005. Structure of the ectodomain of Drosophila peptidoglycan-recognition protein LCa
suggests a molecular mechanism for pattern recognition. Proc. Natl. Acad. Sci. USA
102:10279–84
734 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
122. Chang CI, Chelliah Y, Borek D, Mengin-Lecreulx D, Deisenhofer J. 2006. Structure of
tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor. Science
311:1761–64
123. Reiser JB, Teyton L, Wilson IA. 2004. Crystal structure of the Drosophila peptidoglycan
recognition protein (PGRP)-SA at 1.56 A˚ resolution. J. Mol. Biol. 340:909–17
124. Mellroth P, Karlsson J, Hakansson J, Schultz N, Goldman WE, Steiner H. 2005.
Ligand-induced dimerization of Drosophila peptidoglycan recognition proteins in vitro.
Proc. Natl. Acad. Sci. USA 102:6455–60
125. Takehana A, Katsuyama T, Yano T, Oshima Y, Takada H, et al. 2002. Overexpres-
sion of a pattern-recognition receptor, peptidoglycan-recognition protein-LE, acti-
vates imd/relish-mediated antibacterial defense and the prophenoloxidase cascade in
Drosophila larvae. Proc. Natl. Acad. Sci. USA 99:13705–10
126. Takehana A, Yano T, Mita S, Kotani A, Oshima Y, Kurata S. 2004. Peptidoglycan recog-
nition protein (PGRP)-LE and PGRP-LC act synergistically in Drosophila immunity.
EMBO J. 23:4690–700
127. Kaneko T, Yano T, Aggarwal K, Lim JH, Ueda K, et al. 2006. PGRP-LC and PGRP-LE
have essential yet distinct functions in the Drosophila immune response to monomeric
DAP-type peptidoglycan. Nat. Immunol. 7:715–23
128. Michel T, Reichhart JM, Hoffmann JA, Royet J. 2001. Drosophila Toll is activated by
Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature
414:756–59
129. Gobert V, Gottar M, Matskevich AA, Rutschmann S, Royet J, et al. 2003. Dual activation
of the Drosophila Toll pathway by two pattern recognition receptors. Science 302:2126–30
130. Pili-Floury S, Leulier F, Takahashi K, Saigo K, Samain E, et al. 2004. In vivo RNAi
analysis reveals an unexpected role for GNBP1 in the defense against Gram-positive
bacterial infection in Drosophila adults. J. Biol. Chem. 279:12848–53
130a. Wang L, Weber AN, Atilano ML, Filipe SR, Gay NJ, Ligoxygakis P. 2006. Sensing of
Gram-positive bacteria in Drosophila: GNBP1 is needed to process and present pepti-
doglycan to PGRP-SA. EMBO J. 25:5005–14
131. Bischoff V, Vignal C, Boneca IG, Michel T, Hoffmann JA, Royet J. 2004. Function of
the Drosophila pattern-recognition receptor PGRP-SD in the detection of Gram-positive
bacteria. Nat. Immunol. 5:1175–80
131a. Kim YS, Ryu JH, Han SJ, Choi KH, Nam KB, et al. 2000. Gram-negative bacteria-
binding protein, a pattern recognition receptor for lipopolysaccharide and β-1,3-glucan
that mediates the signaling for the induction of innate immune genes in Drosophila
melanogaster cells. J. Biol. Chem. 275:32721–72
131b. Ochiai M, Ashida M. 1988. Puriﬁcation of a β-1,3-glucan recognition protein in the
prophenoloxidase activating system from hemolymph of the silkworm, Bombyx mori. J.
Biol. Chem. 263:12056–62
131c. Gottar M, Gobert V, Matskevich A, Reichhart JM, Wang C, et al. 2006. Dual detection
of fungal infections in Drosophila by recognition of glucans and sensing of virulence
factors. Cell 127:1425–37
132. Krem MM, Cera ED. 2002. Evolution of enzyme cascades from embryonic development
to blood coagulation. Trends Biochem. Sci. 27:67–74
133. Reichhart JM. 2005. Tip of another iceberg: Drosophila serpins. Trends Cell Biol. 15:659–
65
134. Ross J, Jiang H, Kanost MR, Wang Y. 2003. Serine proteases and their homologs in
the Drosophila melanogaster genome: an initial analysis of sequence conservation and
phylogenetic relationships. Gene 304:117–31
www.annualreviews.org • Host Defense of Drosophila melanogaster 735
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
135. Lee KY, Zhang R, Kim MS, Park JW, Park HY, et al. 2002. A zymogen form of
masquerade-like serine proteinase homologue is cleaved during prophenoloxidase acti-
vation by Ca2+ in coleopteran and Tenebrio molitor larvae. Eur. J. Biochem. 269:4375–83
136. Yu XQ, Jiang H, Wang Y, Kanost MR. 2003. Nonproteolytic serine proteinase homologs
are involved in prophenoloxidase activation in the tobacco hornworm, Manduca sexta.
Insect. Biochem. Mol. Biol. 33:197–208
137. Piao S, Song YL, Kim JH, Park SY, Park JW, et al. 2005. Crystal structure of a clip-
domain serine protease and functional roles of the clip domains. EMBO J. 24:4404–14
138. Kambris Z, Brun S, Jang IH, Nam HJ, Romeo Y, et al. 2006. Drosophila immunity: A
large-scale in vivo RNAi screen identiﬁes ﬁve serine proteases required for Toll activa-
tion. Curr. Biol. 16:808–13
139. Jang IH, Chosa N, Kim SH, Nam HJ, Lemaitre B, et al. 2006. A Spa¨tzle-processing
enzyme required for Toll signaling activation in Drosophila innate immunity. Dev. Cell
10:45–55
140. Ligoxygakis P, Pelte N, Hoffmann JA, Reichhart JM. 2002. Activation of Drosophila
Toll during fungal infection by a blood serine protease. Science 297:114–16
141. Levashina EA, Langley E, Green C, Gubb D, Ashburner M, et al. 1999. Constitu-
tive activation of Toll-mediated antifungal defense in serpin-deﬁcient Drosophila. Science
285:1917–19
142. Lemaitre B, Meister M, Govind S, Georgel P, Steward R, et al. 1995. Functional analysis
and regulation of nuclear import of dorsal during the immune response in Drosophila.
EMBO J. 14:536–45
143. Ligoxygakis P, Pelte N, Ji C, Leclerc V, Duvic B, et al. 2002. A serpin mutant links Toll
activation to melanization in the host defense of Drosophila. EMBO J. 21:6330–37
144. Scherfer C, Qazi MR, Takahashi K, Ueda R, Dushay MS, et al. 2006. The Toll immune-
regulated Drosophila protein Fondue is involved in hemolymph clotting and puparium
formation. Dev. Biol. 295:156–63
145. Mukae N, Yokoyama H, Yokokura T, Sakoyama Y, Nagata S. 2002. Activation of the
innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic
degradation. Genes Dev. 16:2662–71
146. Daffre S, Kylsten P, Samakovlis C, Hultmark D. 1994. The lysozyme locus in Drosophila
melanogaster: an expanded gene family adapted for expression in the digestive tract. Mol.
Gen. Genet. 242:152–62
147. Hultmark D. 1996. Insect lysozymes. EXS 75:87–102
148. Brey PT, Lee WJ, Yamakawa M, Koizumi Y, Perrot S, et al. 1993. Role of the integument
in insect immunity: epicuticular abrasion and induction of cecropin synthesis in cuticular
epithelial cells. Proc. Natl. Acad. Sci. USA 90:6275–79
149. Ferrandon D, Jung AC, Criqui M, Lemaitre B, Uttenweiler-Joseph S, et al. 1998. A
drosomycin-GFP reporter transgene reveals a local immune response in Drosophila that
is not dependent on the Toll pathway. EMBO J. 17:1217–27
150. Ryu JH, Nam KB, Oh CT, Nam HJ, Kim SH, et al. 2004. The homeobox gene Cau-
dal regulates constitutive local expression of antimicrobial peptide genes in Drosophila
epithelia. Mol. Cell. Biol. 24:172–85
151. Han SH, Ryu JH, Oh CT, Nam KB, Nam HJ, et al. 2004. The moleskin gene product
is essential for Caudal-mediated constitutive antifungal Drosomycin gene expression in
Drosophila epithelia. Insect. Mol. Biol. 13:323–27
152. Peng J, Zipperlen P, Kubli E. 2005. Drosophila sex peptide stimulates female innate
immune system after mating via the Toll and Imd pathways. Curr. Biol. 15:1690–94
736 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
153. O¨nfelt Tingvall T, Roos E, Engstrom Y. 2001. The imd gene is required for local Cecropin
expression in Drosophila barrier epithelia. EMBO Rep. 2:239–43
154. Basset A, Khush RS, Braun A, Gardan L, Boccard F, et al. 2000. The phytopathogenic
bacteria, Erwinia carotovora, infects Drosophila and activates an immune response. Proc.
Natl. Acad. Sci. USA 97:3376–81
155. Ritsick DR, Edens WA, McCoy JW, Lambeth JD. 2004. The use of model systems to
study biological functions of Nox/Duox enzymes. Biochem. Soc. Symp. 2004:85–96
156. Ha EM, Oh CT, Bae YS, Lee WJ. 2005. A direct role for dual oxidase in Drosophila gut
immunity. Science 310:847–50
157. Ha EM, Oh CT, Ryu JH, Bae YS, Kang SW, et al. 2005. An antioxidant system required
for host protection against gut infection in Drosophila. Dev. Cell 8:125–32
158. Ryu JH, Ha EM, Oh CT, Seol JH, Brey PT, et al. 2006. An essential complementary
role of NF-κB pathway to microbicidal oxidants in Drosophila gut immunity. EMBO J.
25:3693–701
159. Rizki TM. 1978. The circulatory system and associated cells and tissues. In The Genet-
ics and Biology of Drosophila, ed. M Ashburner, TRF Wright, pp. 397–452. New York:
Academic
160. Lanot R, Zachary D, Holder F, Meister M. 2000. Post-embryonic hematopoiesis in
Drosophila. Dev. Biol. 230:243–57
161. Rizki T, Rizki R, Grell E. 1980. A mutant affecting the crystal cells in Drosophila
melanogaster. Roux’s Arch. Dev. Biol. 188:91–99
162. Tepass U, Fessler LI, Aziz A, Hartenstein V. 1994. Embryonic origin of hemocytes and
their relationship to cell death in Drosophila. Development 120:1829–37
163. Holz A, Bossinger B, Strasser T, Janning W, Klapper R. 2003. The two origins of
hemocytes in Drosophila. Development 130:4955–62
164. Evans CJ, Hartenstein V, Banerjee U. 2003. Thicker than blood: conserved mechanisms
in Drosophila and vertebrate hematopoiesis. Dev. Cell 5:673–90
165. Meister M. 2004. Blood cells of Drosophila: cell lineages and role in host defense. Curr.
Opin. Immunol. 16:10–15
166. Shresta R, Gateff E. 1982. Ultrastructure and cytochemistry of the cell-types in the
tumorous hematopoietic organs and the hemolymph of the mutant lethal (1) malign
blood neoplasm (l(1)mbn) of Drosophila melanogaster. Dev. Growth Differ. 24:83–98
167. Lebestky T, Jung SH, Banerjee U. 2003. A Serrate-expressing signaling center controls
Drosophila hematopoiesis. Genes Dev. 17:348–53
168. Jung SH, Evans CJ, Uemura C, Banerjee U. 2005. The Drosophila lymph gland as a
developmental model of hematopoiesis. Development 132:2521–33
169. Ramet M, Pearson A, Manfruelli P, Li X, Koziel H, et al. 2001. Drosophila scavenger
receptor CI is a pattern recognition receptor for bacteria. Immunity 15:1027–38
170. Pearson A, Lux A, Krieger M. 1995. Expression cloning of dSR-CI, a class C
macrophage-speciﬁc scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad.
Sci. USA 92:4056–60
171. Kocks C, Cho JH, Nehme N, Ulvila J, Pearson AM, et al. 2005. Eater, a transmembrane
protein mediating phagocytosis of bacterial pathogens in Drosophila. Cell 123:335–46
172. Watson FL, Puttmann-Holgado R, Thomas F, Lamar DL, Hughes M, et al. 2005.
Extensive diversity of Ig-superfamily proteins in the immune system of insects. Science
309:1874–78
173. Franc N, Dimarcq J, Lagueux M, Hoffmann J, Ezekowitz R. 1996. Croquemort, a
novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immu-
nity 4:431–43
www.annualreviews.org • Host Defense of Drosophila melanogaster 737
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
174. Garver LS, Wu J, Wu LP. 2006. The peptidoglycan recognition protein PGRP-SC1a is
essential for Toll signaling and phagocytosis of Staphylococcus aureus in Drosophila. Proc.
Natl. Acad. Sci. USA 103:660–65
175. Ju JS, Cho MH, Brade L, Kim JH, Park JW, et al. 2006. A novel 40-kDa protein
containing six repeats of an epidermal growth factor-like domain functions as a pattern
recognition protein for lipopolysaccharide. J. Immunol. 177:1838–45
176. Philips JA, Rubin EJ, Perrimon N. 2005. Drosophila RNAi screen reveals CD36 family
member required for mycobacterial infection. Science 309:1251–53
177. Agaisse H, Burrack LS, Philips JA, Rubin EJ, Perrimon N, Higgins DE. 2005. Genome-
wide RNAi screen for host factors required for intracellular bacterial infection. Science
309:1248–51
178. Stroschein-Stevenson SL, Foley E, O’Farrell PH, Johnson AD. 2006. Identiﬁcation of
Drosophila gene products required for phagocytosis of Candida albicans. PLoS Biol. 4:e4
179. Benghezal M, Fauvarque MO, Tournebize R, Froquet R, Marchetti A, et al. 2006. Spe-
ciﬁc host genes required for the killing of Klebsiella bacteria by phagocytes. Cell. Microbiol.
8:139–48
180. Pearson AM, Baksa K, Ramet M, Protas M, McKee M, et al. 2003. Identiﬁcation of
cytoskeletal regulatory proteins required for efﬁcient phagocytosis in Drosophila. Microbes
Infect. 5:815–24
181. Seong CS, Varela-Ramirez A, Aguilera RJ. 2006. DNase II deﬁciency impairs innate
immune function in Drosophila. Cell. Immunol. 240:5–13
182. Blandin S, Shiao SH, Moita LF, Janse CJ, Waters AP, et al. 2004. Complement-like
protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles
gambiae. Cell 116:661–70
183. Eslin P, Doury G. 2006. The ﬂy Drosophila subobscura: a natural case of innate immunity
deﬁciency. Dev. Comp. Immunol. 30:977–83
184. Russo J, Dupas S, Frey F, Carton Y, Brehelin M. 1996. Insect immunity: early events
in the encapsulation process of parasitoid (Leptopilina boulardi) eggs in resistant and
susceptible strains of Drosophila. Parasitology 112:135–42
185. Nappi AJ, Vass E, Frey F, Carton Y. 1995. Superoxide anion generation in Drosophila
during melanotic encapsulation of parasites. Eur. J. Cell Biol. 68:450–56
186. Irving P, Ubeda JM, Doucet D, Troxler L, Lagueux M, et al. 2005. New insights into
Drosophila larval haemocyte functions through genome-wide analysis. Cell. Microbiol.
7:335–50
187. Lavine MD, Strand MR. 2003. Haemocytes from Pseudoplusia includens express multiple
α and β integrin subunits. Insect. Mol. Biol. 12:441–52
188. Williams MJ, Ando I, Hultmark D. 2005. Drosophila melanogaster Rac2 is necessary for
a proper cellular immune response. Genes Cells 10:813–23
189. Williams MJ, Wiklund ML, Wikman S, Hultmark D. 2006. Rac1 signaling in the
Drosophila larval cellular immune response. J. Cell Sci. 119:2015–24
190. Kurucz E, Zettervall C, Sinka R, Vilmos P, Pivarcsi A, et al. 2003. Hemese, a hemocyte-
speciﬁc transmembrane protein, affects the cellular immune response in Drosophila. Proc.
Natl. Acad. Sci. USA 100:2622–27
191. Wertheim B, Kraaijeveld AR, Schuster E, Blanc E, Hopkins M, et al. 2005. Genome-
wide gene expression in response to parasitoid attack in Drosophila. Genome Biol. 6:R94
192. Rizki RM, Rizki TM. 1980. Hemocyte responses to implanted tissues in Drosophila
melanogaster larvae. Roux Arch. Dev. Biol. 189:207–13
193. Crozatier M, Ubeda JM, Vincent A, Meister M. 2004. Cellular immune response to
parasitization in Drosophila requires the EBF orthologue collier. PLoS Biol. 2:e196
738 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
194. Sparrow JC. 1978. Melanotic “tumours.” In The Genetics and Biology of Drosophila, ed. M
Ashburner, TRF Wright, 2B:277–313. London: Academic
194a. Minakhina S, Steward R. 2006. Melanotic mutants in Drosophila: pathways and pheno-
types. Genetics 174:253–63
195. Watson KL, Johnson TK, Denell RE. 1991. Lethal(1) aberrant immune response mutations
leading to melanotic tumor formation in Drosophila melanogaster. Dev. Genet. 12:173–87
196. Hanratty WP, Dearolf CR. 1993. The Drosophila Tumorous-lethal hematopoietic onco-
gene is a dominant mutation in the hopscotch locus. Mol. Gen. Genet. 238:33–37
197. Goto A, Kadowaki T, Kitagawa Y. 2003. Drosophila hemolectin gene is expressed in em-
bryonic and larval hemocytes and its knock down causes bleeding defects. Dev. Biol.
264:582–91
198. Fessler LI, Nelson RE, Fessler JH. 1994. Drosophila extracellular matrix. Methods Enzy-
mol. 245:271–94
199. Reichhart JM, Meister M, Dimarcq JL, Zachary D, Hoffmann D, et al. 1992. Insect
immunity: developmental and inducible activity of the Drosophila diptericin promoter.
EMBO J. 11:1469–77
200. Samakovlis C, Asling B, Boman HG, Gateff E, Hultmark D. 1992. In vitro induction of
cecropin genes: an immune response in a Drosophila blood cell line. Biochem. Biophys. Res.
Commun. 188:1169–75
201. Muta T, Iwanaga S. 1996. The role of hemolymph coagulation in innate immunity.
Curr. Opin. Immunol. 8:41–47
202. So¨derha¨ll K, Cerenius L, Johansson MW. 1996. The prophenoloxidase activating sys-
tem in invertebrates. In New Directions in Invertebrate Immunology, ed. K So¨derha¨ll, S
Iwanaga, GR Vasta, pp. 229–53. Fair Haven, NJ: SOS Publ.
203. Scherfer C, Karlsson C, Loseva O, Bidla G, Goto A, et al. 2004. Isolation and charac-
terization of hemolymph clotting factors in Drosophila melanogaster by a pullout method.
Curr. Biol. 14:625–29
204. Karlsson C, Korayem AM, Scherfer C, Loseva O, Dushay MS, Theopold U. 2004.
Proteomic analysis of the Drosophila larval hemolymph clot. J. Biol. Chem. 279:52033–
41
205. Bidla G, Lindgren M, Theopold U, Dushay MS. 2005. Hemolymph coagulation and
phenoloxidase in Drosophila larvae. Dev. Comp. Immunol. 29:669–79
206. Nappi AJ, Vass E. 1993. Melanogenesis and the generation of cytotoxic molecules during
insect cellular immune reactions. Pigment Cell Res. 6:117–26
207. Ashida M. 1990. The prophenoloxidase cascade in insect immunity. Res. Immunol.
141:908–10
208. So¨derha¨ll K, Cerenius L. 1998. Role of prophenoloxidase-activating system in inverte-
brate immunity. Curr. Opin. Immunol. 10:23–28
209. Ochiai M, Ashida M. 1999. A pattern recognition protein for peptidoglycan. Cloning
the cDNA and the gene of the silkworm, Bombyx mori. J. Biol. Chem. 274:11854–58
210. Ochiai M, Ashida M. 2000. A pattern-recognition protein forβ-1,3-glucan. The binding
domain and the cDNA cloning of β-1,3-glucan recognition protein from the silkworm,
Bombyx mori. J. Biol. Chem. 275:4995–5002
211. Ma C, Kanost MR. 2000. A β1,3-glucan recognition protein from an insect, Manduca
sexta, agglutinates microorganisms and activates the phenoloxidase cascade. J. Biol. Chem.
275:7505–14
212. Lee MH, Osaki T, Lee JY, Baek MJ, Zhang R, et al. 2003. Peptidoglycan recognition
proteins involved in 1,3-β-D-glucan-dependent prophenoloxidase activation system of
insect. J. Biol. Chem. 279:3218–27
www.annualreviews.org • Host Defense of Drosophila melanogaster 739
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
213. Braun A, Hoffmann JA, Meister M. 1998. Analysis of the Drosophila host defense in domino
mutant larvae, which are devoid of hemocytes. Proc. Natl. Acad. Sci. USA 95:14337–42
214. De Gregorio E, Han SJ, Lee WJ, Baek MJ, Osaki T, et al. 2002. An immune-responsive
Serpin regulates the melanization cascade in Drosophila. Dev. Cell 3:581–92
215. Castillejo-Lopez C, Hacker U. 2005. The serine protease Sp7 is expressed in blood cells
and regulates the melanization reaction in Drosophila. Biochem. Biophys. Res. Commun.
338:1075–82
216. Leclerc V, Pelte N, El Chamy L, Martinelli C, Ligoxygakis P, et al. 2005. Prophenolox-
idase activation is not required for survival to microbial infections in Drosophila. EMBO
Rep. 7:231–35
217. Tang H, Kambris Z, Lemaitre B, Hashimoto C. 2006. Two proteases deﬁning a melaniza-
tion cascade in the immune system of Drosophila. J. Biol. Chem. 281:28097–104
218. Ashburner M, Golic KG, Hawley RS. 2005. Parasites, pests, and diseases. In Drosophila,
A Laboratory Handbook, ed. M Ashburner, pp. 1285–333. New York: Cold Spring Harbor
Lab. Press. 2nd ed.
219. Vodovar N, Acosta C, Lemaitre B, Boccard F. 2004. Drosophila: a polyvalent model to
decipher host-pathogen interactions. Trends Microbiol. 12:235–42
220. Elrod-Erickson M, Mishra S, Schneider D. 2000. Interactions between the cellular and
humoral immune responses in Drosophila. Curr. Biol. 10:781–84
221. D’Argenio DA, Gallagher LA, Berg CA, Manoil C. 2001. Drosophila as a model host for
Pseudomonas aeruginosa infection. J. Bacteriol. 183:1466–71
222. Flyg C, Kenne K, Boman HG. 1980. Insect pathogenic properties of Serratia marcescens:
phage-resistant mutants with a decreased resistance to Cecropia immunity and a de-
creased virulence to Drosophila. J. Gen. Microbiol. 120:173–81
223. Kurz CL, Chauvet S, Andres E, Aurouze M, Vallet I, et al. 2003. Virulence factors of
the human opportunistic pathogen Serratia marcescens identiﬁed by in vivo screening.
EMBO J. 22:1451–60
224. Lau GW, Goumnerov BC, Walendziewicz CL, Hewitson J, Xiao W, et al. 2003. The
Drosophila melanogaster Toll pathway participates in resistance to infection by the gram-
negative human pathogen Pseudomonas aeruginosa. Infect. Immun. 71:4059–66
225. Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL, et al. 2005. Proﬁling
early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing
antimicrobial peptide gene expression. Proc. Natl. Acad. Sci. USA 102:2573–78
226. Chugani SA, Whiteley M, Lee KM, D’Argenio D, Manoil C, Greenberg EP. 2001.
QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas
aeruginosa. Proc. Natl. Acad. Sci. USA 98:2752–57
227. Fauvarque MO, Bergeret E, Chabert J, Dacheux D, Satre M, Attree I. 2002. Role and
activation of type III secretion system genes in Pseudomonas aeruginosa–induced Drosophila
killing. Microb. Pathog. 32:287–95
228. Avet-Rochex A, Bergeret E, Attree I, Meister M, Fauvarque MO. 2005. Suppression of
Drosophila cellular immunity by directed expression of the ExoS toxin GAP domain of
Pseudomonas aeruginosa. Cell. Microbiol. 7:799–810
229. Dionne MS, Ghori N, Schneider DS. 2003. Drosophila melanogaster is a genetically
tractable model host for Mycobacterium marinum. Infect. Immun. 71:3540–50
229a. Dionne MS, Pham LN, Shirasu-Hiza M, Schneider DS. 2006. Akt and FOXO dysreg-
ulation contribute to infection-induced wasting in Drosophila. Curr. Biol. 16:1977–85
230. Brandt SM, Dionne MS, Khush RS, Pham LN, Vigdal TJ, Schneider DS. 2004. Secreted
bacterial effectors and host-produced Eiger/TNF drive death in a Salmonella-infected
fruit ﬂy. PLoS Biol. 2:e418
740 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
231. Rahme LG, Ausubel FM, Cao H, Drenkard E, Goumnerov BC, et al. 2000. Plants and
animals share functionally common bacterial virulence factors. Proc. Natl. Acad. Sci. USA
97:8815–21
232. Ewbank JJ. 2002. Tackling both sides of the host-pathogen equation with Caenorhabditis
elegans. Microbes Infect. 4:247–56
233. Cheng LW, Portnoy DA. 2003. Drosophila S2 cells: an alternative infection model for
Listeria monocytogenes. Cell. Microbiol. 5:875–85
234. Elwell C, Engel JN. 2005. Drosophila melanogaster S2 cells: a model system to study
Chlamydia interaction with host cells. Cell. Microbiol. 7:725–39
235. Basset A, Tzou P, Lemaitre B, Boccard F. 2003. A single gene that promotes interactions
of a phytopathogenic bacterium with its insect vector, Drosophila melanogaster. EMBO
Rep. 4:205–9
236. Muniz CA, Jaillard D, Lemaitre B, Boccard F. 2007. Erwinia carotovora Evf antagonizes
the elimination of bacteria in the gut of Drosophila larvae. Cell. Microbiol. 9:106–19
237. Vodovar N, Vinals M, Liehl P, Basset A, Degrouard J, et al. 2005. Drosophila host defense
after oral infection by an entomopathogenic Pseudomonas species. Proc. Natl. Acad. Sci.
USA 102:11414–19
238. Liehl P, Blight M, Vodovar N, Boccard F, Lemaitre B. 2006. Prevalence of local immune
response against oral infection in a Drosophila/Pseudomonas infection model. PLoS Pathog.
2:e56
239. Vodovar N, Vallenet D, Cruveiller S, Rouy Z, Barbe V, et al. 2006. Complete genome se-
quence of the entomopathogenic and metabolically versatile soil bacterium Pseudomonas
entomophila. Nat. Biotechnol. 24:673–79
240. Nappi AJ, Vass E, Frey F, Carton Y. 2000. Nitric oxide involvement in Drosophila im-
munity. Nitric Oxide 4:423–30
241. Foley E, O’Farrell PH. 2003. Nitric oxide contributes to induction of innate immune
responses to gram-negative bacteria in Drosophila. Genes Dev. 17:115–25
242. Clarkson JM, Charnley AK. 1996. New insights into the mechanisms of fungal patho-
genesis in insects. Trends Microbiol. 4:197–203
243. Alarco AM, Marcil A, Chen J, Suter B, Thomas D, Whiteway M. 2004. Immune-
deﬁcient Drosophila melanogaster: a model for the innate immune response to human
fungal pathogens. J. Immunol. 172:5622–28
244. Carton Y, Bouletreau M, van Alphen JJM, van Lenteren JC. 1986. The Drosophila par-
asitic wasps. In The Genetics and Biology of Drosophila, ed. M Ashburner, HL Carson, JN
Thompson, pp. 347–94. New York: Academic
245. Hita M, Espagne E, Lemeunier F, Pascual L, Carton Y, et al. 2006. Mapping candidate
genes for Drosophila melanogaster resistance to the parasitoid wasp Leptopilina boulardi.
Genet. Res. 88:81–91
245a. Dubuffet A, Dupas S, Frey F, Drezen JM, Poirie M, Carton Y. 2007. Genetic interactions
between the parasitoid wasp Leptopilina boulardi and its Drosophila hosts. Heredity. 98:21–
27
246. Kraaijeveld AR, van Alphen JJM. 1994. Geographical variation in resistance of the
parasitoids Asobara tabida against encapsulation by Drosophila melanogaster larvae: the
mechanisms explored. Physiol. Entomol. 19:9–14
247. Prevost G, Eslin P, Doury G, Moreau SJ, Guillot S. 2005. Asobara, braconid parasitoids
of Drosophila larvae: unusual strategies to avoid encapsulation without VLPs. J. Insect.
Physiol. 51:171–79
www.annualreviews.org • Host Defense of Drosophila melanogaster 741
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
248. Eslin P, Prevost G. 2000. Racing against host’s immunity defenses: a likely strategy for
passive evasion of encapsulation in Asobara tabida parasitoids. J. Insect. Physiol. 46:1161–
67
249. Rizki RM, Rizki TM. 1984. Selective destruction of a host blood cell type by a parasitoid
wasp. Proc. Natl. Acad. Sci. USA 81:6154–58
250. Rizki RM, Rizki TM. 1990. Parasitoid virus-like particles destroy Drosophila cellular
immunity. Proc. Natl. Acad. Sci. USA 87:8388–92
251. Rizki TM, Rizki RM, Carton Y. 1990. Leptopilina heterotoma and L. boulardi: strategies
to avoid cellular defense responses of Drosophila melanogaster. Exp. Parasitol. 70:466–75
252. Labrosse C, Eslin P, Doury G, Drezen JM, Poirie´ M. 2005. Haemocyte changes in D.
melanogaster in response to long gland components of the parasitoid wasp Leptopilina
boulardi: a Rho-GAP protein as an important factor. J. Insect. Physiol. 51:161–70
253. Labrosse C, Stasiak K, Lesobre J, Grangeia A, Huguet E, et al. 2005. A RhoGAP protein
as a main immune suppressive factor in the Leptopilina boulardi (Hymenoptera, Figitidae)–
Drosophila melanogaster interaction. Insect. Biochem. Mol. Biol. 35:93–103
254. Chiu H, Morales J, Govind S. 2006. Identiﬁcation and immuno-electron microscopy
localization of p40, a protein component of immunosuppressive virus-like particles from
Leptopilina heterotoma, a virulent parasitoid wasp of Drosophila. J. Gen. Virol. 87:461–70
255. Morales J, Chiu H, Oo T, Plaza R, Hoskins S, Govind S. 2005. Biogenesis, structure, and
immune-suppressive effects of virus-like particles of a Drosophila parasitoid, Leptopilina
victoriae. J. Insect. Physiol. 51:181–95
256. Moreau SJ, Eslin P, Giordanengo P, Doury G. 2003. Comparative study of the strategies
evolved by two parasitoids of the genus Asobara to avoid the immune response of the
host, Drosophila melanogaster. Dev. Comp. Immunol. 27:273–82
257. Brun G, Plus N. 1980. The viruses of Drosophila. In The Genetics and Biology of Drosophila,
ed. M Ashburner, TRF Wright, pp. 625–702. New York: Academic
257a. Habayeb MS, Ekengren SK, Hultmark D. 2006. Nora virus, a persistent virus in
Drosophila, deﬁnes a new picorna-like virus family. J. Gen. Virol. 87:3045–51
258. Contamine D, Petitjean AM, Ashburner M. 1989. Genetic resistance to viral infection:
the molecular cloning of a Drosophila gene that restricts infection by the rhabdovirus
sigma. Genetics 123:525–33
259. Wayne ML, Contamine D, Kreitman M. 1996. Molecular population genetics of ref(2)P,
a locus which confers viral resistance in Drosophila. Mol. Biol. Evol. 13:191–99
260. Wyers F, Petitjean AM, Dru P, Gay P, Contamine D. 1995. Localization of domains
within the Drosophila Ref(2)P protein involved in the intracellular control of sigma rhab-
dovirus multiplication. J. Virol. 69:4463–70
261. Cherry S, Perrimon N. 2004. Entry is a rate-limiting step for viral infection in a Drosophila
melanogaster model of pathogenesis. Nat. Immunol. 5:81–87
262. Cherry S, Doukas T, Armknecht S, Whelan S, Wang H, et al. 2005. Genome-wide RNAi
screen reveals a speciﬁc sensitivity of IRES-containing RNA viruses to host translation
inhibition. Genes Dev. 19:445–52
262a. Cherry S, Kunte A, Wang H, Coyne C, Rawson RB, Perrimon N. 2006. COPI activity
coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog. 2:e102
263. Sabatier L, Jouanguy E, Dostert C, Zachary D, Dimarcq JL, et al. 2003. Pherokine-2
and -3. Eur. J. Biochem. 270:3398–407
264. Zambon RA, Nandakumar M, Vakharia VN, Wu LP. 2005. The Toll pathway is impor-
tant for an antiviral response in Drosophila. Proc. Natl. Acad. Sci. USA 102:7257–62
265. Cherry S, Silverman N. 2006. Host-pathogen interactions in Drosophila: new tricks from
an old friend. Nat. Immunol. 7:911–17
742 Lemaitre · Hoffmann
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
ANRV306-IY25-24 ARI 11 February 2007 13:14
266. Roxstrom-Lindquist K, Terenius O, Faye I. 2004. Parasite-speciﬁc immune response in
adult Drosophila melanogaster: a genomic study. EMBO Rep. 5:207–12
267. Wang XH, Aliyari R, Li WX, Li HW, Kim K, et al. 2006. RNA interference directs
innate immunity against viruses in adult Drosophila. Science 312:452–54
268. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL. 2006. Essential
function in vivo for Dicer-2 in host defense against RNA viruses in Drosophila. Nat.
Immunol. 7:590–97
269. Zambon RA, Vakharia VN, Wu LP. 2006. RNAi is an antiviral immune response against
a dsRNA virus in Drosophila melanogaster. Cell. Microbiol. 8:880–89
269a. van Rij RP, Saleh MC, Berry B, Foo C, Houk A, et al. 2006. The RNA silencing en-
donuclease Argonaute 2 mediates speciﬁc antiviral immunity in Drosophila melanogaster.
Genes Dev. 20:2985–95
270. Obbard DJ, Jiggins FM, Halligan DL, Little TJ. 2006. Natural selection drives ex-
tremely rapid evolution in antiviral RNAi genes. Curr. Biol. 16:580–85
271. Jiggins FM, Kim KW. 2005. The evolution of antifungal peptides in Drosophila. Genetics
171:1847–59
272. Choe KM, Lee H, Anderson KV. 2005. Drosophila peptidoglycan recognition protein
LC (PGRP-LC) acts as a signal-transducing innate immune receptor. Proc. Natl. Acad.
Sci. USA 102:1122–26
273. Hu S, Yang X. 2000. dFADD, a novel death domain–containing adapter protein for the
Drosophila caspase DREDD. J. Biol. Chem. 275:30761–64
274. Stoven S, Ando I, Kadalayil L, Engstro¨m Y, Hultmark D. 2000. Activation of the
Drosophila NF-κB factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 1:347–52
275. Stoven S, Silverman N, Junell A, Hedengren-Olcott M, Erturk D, et al. 2003. Caspase-
mediated processing of the Drosophila NF-κB factor Relish. Proc. Natl. Acad. Sci. USA
100:5991–96
276. Sorrentino RP, Melk JP, Govind S. 2004. Genetic analysis of contributions of dorsal
group and JAK-Stat92E pathway genes to larval hemocyte concentration and the egg
encapsulation response in Drosophila. Genetics 166:1343–56
277. Huang L, Ohsako S, Tanda S. 2005. The lesswright mutation activates Rel-related
proteins, leading to overproduction of larval hemocytes in Drosophila melanogaster. Dev.
Biol. 280:407–20
www.annualreviews.org • Host Defense of Drosophila melanogaster 743
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
AR306-FM ARI 13 February 2007 11:22
Annual Review of
Immunology
Volume 25, 2007Contents
Frontispiece
Peter C. Doherty                                                                              x
Challenged by Complexity: My Twentieth Century in Immunology
Peter C. Doherty                                                                             1
The Impact of Glycosylation on the Biological Function and Structure
of Human Immunoglobulins
James N. Arnold, Mark R. Wormald, Robert B. Sim, Pauline M. Rudd,
and Raymond A. Dwek                                                                   21
The Multiple Roles of Osteoclasts in Host Defense: Bone Remodeling
and Hematopoietic Stem Cell Mobilization
Orit Kollet, Ayelet Dar, and Tsvee Lapidot                                                51
Flying Under the Radar: The Immunobiology of Hepatitis C
Lynn B. Dustin and Charles M. Rice                                                      71
Resolution Phase of Inﬂammation: Novel Endogenous
Anti-Inﬂammatory and Proresolving Lipid Mediators and Pathways
Charles N. Serhan                                                                        101
Immunobiology of Allogeneic Hematopoietic Stem Cell
Transplantation
Lisbeth A. Welniak, Bruce R. Blazar, and William J. Murphy                       139
Effector and Memory CTL Differentiation
Matthew A. Williams and Michael J. Bevan                                           171
TSLP: An Epithelial Cell Cytokine that Regulates T Cell
Differentiation by Conditioning Dendritic Cell Maturation
Yong-Jun Liu, Vasilli Soumelis, Norihiko Watanabe, Tomoki Ito,
Yui-Hsi Wang, Rene de Waal Malefyt, Miyuki Omori, Baohua Zhou,
and Steven F. Ziegler                                                                   193
Discovery and Biology of IL-23 and IL-27: Related but Functionally
Distinct Regulators of Inﬂammation
Robert A. Kastelein, Christopher A. Hunter, and Daniel J. Cua                      221
v
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
AR306-FM ARI 13 February 2007 11:22
Improving T Cell Therapy for Cancer
Ann M. Leen, Cliona M. Rooney, and Aaron E. Foster                                243
Immunosuppressive Strategies that are Mediated by Tumor Cells
Gabriel A. Rabinovich, Dmitry Gabrilovich, and Eduardo M. Sotomayor            267
The Biology of NKT Cells
Albert Bendelac, Paul B. Savage, and Luc Teyton                                      297
Regulation of Cellular and Humoral Immune Responses by the SLAM
and SAP Families of Molecules
Cindy S. Ma, Kim E. Nichols, and Stuart G. Tangye                                  337
Mucosal Dendritic Cells
Akiko Iwasaki                                                                             381
Immunologically Active Autoantigens: The Role of Toll-Like
Receptors in the Development of Chronic Inﬂammatory Disease
Ann Marshak-Rothstein and Ian R. Rifkin                                             419
The Immunobiology of SARS
Jun Chen and Kanta Subbarao                                                          443
Nonreceptor Protein-Tyrosine Phosphatases in Immune Cell Signaling
Lily I. Pao, Karen Badour, Katherine A. Siminovitch, and Benjamin G. Neel       473
Fc Receptor-Like Molecules
Randall S. Davis                                                                          525
The Death Domain Superfamily in Intracellular Signaling of Apoptosis
and Inﬂammation
Hyun Ho Park, Yu-Chih Lo, Su-Chang Lin, Liwei Wang, Jin Kuk Yang,
and Hao Wu                                                                            561
Cellular Responses to Viral Infection in Humans: Lessons from
Epstein-Barr Virus
Andrew D. Hislop, Graham S. Taylor, Delphine Sauce, and Alan B. Rickinson      587
Structural Basis of Integrin Regulation and Signaling
Bing-Hao Luo, Christopher V. Carman, and Timothy A. Springer                   619
Zoned Out: Functional Mapping of Stromal Signaling
Microenvironments in the Thymus
Howard T. Petrie and Juan Carlos Zu´n˜iga-Pﬂu¨cker                                   649
T Cells as a Self-Referential, Sensory Organ
Mark M. Davis, Michelle Krogsgaard, Morgan Huse, Johannes Huppa,
Bjoern F. Lillemeier, and Qi-jing Li                                                   681
The Host Defense of Drosophila melanogaster
Bruno Lemaitre and Jules Hoffmann                                                   697
vi Contents
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
AR306-FM ARI 13 February 2007 11:22
Ontogeny of the Hematopoietic System
Ana Cumano and Isabelle Godin                                                        745
Chemokine:Receptor Structure, Interactions, and Antagonism
Samantha J. Allen, Susan E. Crown, and Tracy M. Handel                          787
IL-17 Family Cytokines and the Expanding Diversity of Effector
T Cell Lineages
Casey T. Weaver, Robin D. Hatton, Paul R. Mangan, and Laurie E. Harrington   821
Indexes
Cumulative Index of Contributing Authors, Volumes 15–25                        853
Cumulative Index of Chapter Titles, Volumes 15–25                                 860
Errata
An online log of corrections to Annual Review of Immunology chapters (if any, 1997 to
the present) may be found at http://immunol.annualreviews.org/errata.shtml
Contents vii
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
7.
25
:6
97
-7
43
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 E
co
le
 P
ol
yt
ec
hn
iq
ue
 F
ed
er
al
 L
au
sa
nn
e 
on
 0
8/
23
/1
3.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
